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Abstract 
The present study aims to examine the effects of prenatal cocaine 
exposure on the developmental changes of rat striatal dopamineregic system in 
the offspring. This include the biochemical studies as well as the molecular 
genetic studies of the dopamine transporter and dopamine receptors. 
Morphological studies to localize changes in dopaminergic fibre and cell 
densities were also made. 
Pregnant Sprague-Dawley rats were dosed once each day orally with 60 
mg/kg/day cocaine hydrochloride from gestation days 7 to 21. Control animals 
received an equivalent volume of water. The striatum from the offspring at 
postnatal 0 to 32 weeks were examined. Biochemical studies include receptor 
binding assays and Scatchard analysis of the dopamine transporter (DAT), 
dopamine D! and D: receptors using radioactive ligand [^H]mazindol, [^H]SCH 
23390 and [^H]sulpiride respectively. The changes in the level of mRNA for 
the dopamine transporter and dopamine D: receptor were studied using 
Northern blot analysis and also in situ hybridization was also used to localize 
the changes in DAT. Morphological changes in the distribution of 
dopaminergic neurons were observed using tyrosine hydroxylase 
immunostaining. 
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Results from the present study revealed that there was no significant 
difference in the litter size, pups birth weight and maternal weight gain after 
prenatal cocaine exposure. 
The offspring in the control group showed an age-dependent increase of 
82.1%，93.1% and 86.2% in specific binding of [^H]mazindol-labelled DAT, 
[屯]SCH 23390-labelled D! receptor and [^H]sulpiride-labelled D^ receptor 
respectively, reaching a maximum at postnatal (PN) 4 weeks. Scatchard 
analysis also showed that the number of dopamine transporters ( B ^ reached 
adult levels by PN 4 weeks (B腿：1.71 土 0.04 pmol/mg protein). However, the 
prenatal cocaine-exposed offspring showed a significant decrease of 39% (p < 
0.05) and 21% (p < 0.05) in B腿 at PN 3 and 4 week respectively, with a 
recovery to near normal values by PN 12 weeks. 
In the control group, the Scatchard analysis showed that the number of 
dopamine Dj receptor sites (B腿）reached adult levels at PN 3 weeks (B腿： 
1.02 士 0.08 pmol/mg protein). At PN 12 weeks, the cocaine-exposed group 
showed a significant decrease of 25% and 44% (p < 0.001) in B腿 and K^ of 
dopamine Dj receptor, respectively. 
For the dopamine D�receptor, Scatchard analysis in the control group 
showed that there was an age-dependent increase in the number of dopamine 
D2 receptor sites ( B ^ to PN 32 weeks (B咖：178.0 士 45.0 fmol/mg protein) 
with the most rapid increase during the first 4 weeks of development. There is a 
significant decrease of 33% {p < 0.001) in B腿 of D�receptors in the 
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cocaine-exposed group at PN 0 weeks only. A 58% specific binding value for 
pH]sulpmde at PN 0 weeks as well as the residual materal cocaine 
demonstrated by a significant decrease of 97% in specific binding observed in 
maternal striatal tissue reflected a certain degree of unreliability in the 
significance of this result. 
Tyrosine hydroxylase (TH) immunocytochemical staining showed an 
increase in the density of TH fibers in the caudate putamen (CP) and internal 
capsule (IC) of the cocaine-exposed group at PN 12 weeks only. 
Similar to the receptor binding assay and Scatchard analysis, the 
Northern blot analysis of the dopamine transporter also showed an 
age-dependent increase from PN 0-4 weeks, with a 2.8 fold increase in density 
level at PN 4 weeks when compared to PN 0 weeks. A 20% decrease in mRNA 
levels at PN 4 weeks in the cocaine-exposed group was observed. This 
corresponded to the same period where a 21% decrease in B腿 was also 
observed. The cocaine-exposed group also showed an approximately 25%, 17% 
and 13% increase in density ratio at PN 0，1 and 12 weeks respectively. 
Also similar to that observed by Scatchard analysis. Northern blot 
analysis of the dopamine D: receptor also showed an age-dependent increase 
from PN 0-32 weeks, with a 1.8 fold increase in density ratio at PN 32 weeks 
when compared to PN 0 weeks. The cocaine-exposed group showed an 
approximately 10% increase in density levels at PN 3，4 and 12 weeks when 
compared to the control. 
• • • Vlll 
In situ hybridization study showed dopamine transporter mRNA to be 
localized in the substantia nigra (SN) and ventral tegmental area (VTA) in both 
the control and cocaine-exposed offspring. However, the present study showed 
little qualitative change in ribroprobe density at PN 3 and 4 weeks. 
Biochemical and molecular genetic results from the present study 
showed that prenatal cocaine exposure differentially affects the changes in 
DAT, Di and D^ receptors. At PN 3 and 4 weeks, there was a transient decrease 
in DAT numbers whereas the transient decrease in Dj receptor number and 
binding affinity was observed at PN 12 weeks. There is however minimal 
effects observed for the D: receptors. This transient effect observed may be due 
to a delay in the maturation process. 
Morphological studies showed an increase in TH immunostained fibres 
in the striatum at PN 12 weeks in the cocaine-exposed offspring suggestive of a 
compensatory response and dopaminergic neuron plasticity. This was also 
evident in the slight trend of increase in DAT numbers at PN 32 weeks and the 
increase in mRNA levels at PN 0，1 and 12 weeks in the cocaine-exposed 
offspring. Results so far seemed to suggest that prenatal cocaine exposure 
exerts a transient effect on the nigrostriatal dopaminergic system. 
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CHAPTER I : INTRODUCTION 
1.1 Cocaine 
1.1.1 History 
The earliest evidence of cocaine use by humans dated back to 600 A.D.， 
as evidenced by the findings of coca leaves in the tombs of natives of Peru 
(Byck, 1974; Siegel, 1982). With the establishment of the Inca Kingdom, the 
habit seemed to have spread across large parts of South America. Local tribes 
used leaves of the plant Erythroxylon Coca for religious, mystical, stimulant 
and medical purposes (Carroll, 1977; Grinspoon and Bakalar, 1981; Naranjo, 
1981). Soon after the European discovery of the new world, export of coca 
leaves began in small quantities. Centuries later, in 1855, the active coca 
alkaloid was isolated, chemically defined, and named cocaine (Freud, 1884). 
There are over 200 known species of the genus Erythroxylon but only E. coca 
var. ipadu, E. novogranatense and E. novogranatense var. truxillense contain 
measurable amounts of cocaine (Evans, 1981). 
The local anesthetic quality of cocaine and its application to clinical 
ophthalmic practice was noted some 20 years later (Byck, 1974; Fleming et al.， 
1990) and, in 1884, Freud published a report on the properties of cocaine as a 
local anesthetic and central nervous system (CNS) stimulant. Freud's 
comprehensive description of cocaine remained an authoritative source for the 
next few decades. Cocaine was one of the first alkaloids to be synthesized 
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chemically; its molecular structure was defined in 1955 (Van Dyke and Byck, 
1982). 
The dangers of cocaine had long been recognized, so that by 1891, 200 
reports of cocaine intoxication was documented (Woods and Downs, 1973). 
Cocaine's activity as a CNS stimulant gained popularity in the early 20th 
century. In the last decade cocaine addiction became an epidemic. 
1.1.2 Epidemiology 
Epidemiologic data indicated that cocaine abuse is gaining worldwide 
popularity (Kain et al.，1992). It is now estimated that about 14% of the US 
population had tried cocaine at least once，as compared with about 1 million in 
1979 (0.5%) and 100,000 in 1959 (0.06%) (Van Dyke and Bych, 1982). By 
1985, it was estimated that lifetime prevalence of cocaine abuser to be more 
than 22 million people in the USA (Adams et al, 1987). This was a 2.3 times 
increase in the number of cocaine abusers when compared to that reported in 
1977 (9.8 million). Studies on cocaine abusers undergoing treatment (Helfrich 
et al., 1983; Gawin and Kleber, 1985; Schnoll et al , 1985) reported that the 
average age of cocaine-abuse patients are 20-30 years old and most patients are 
males. The cocaine abusers in these studies were reported to use more than 6g 
per week. The National Institute of Drug Abuse in the USA reported that in 
1986, cocaine abuse became the most frequent cause of drug-related emergency 
department visits, surpassing alcohol and narcotics. It was also shown that there 
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was an almost 9-fold increase between the first 6 months of 1981 and the last 6 
months of 1986，when over 13,300 emergencies were related to cocaine use. It 
was also reported that more than two-thirds of all cocaine-related emergencies 
involved cocaine in combination with other drugs (National Institute on Drug 
Abuse, 1987). 
1.1.3 Pharmacology 
Illicit cocaine is sold as a white crystalline powder, cocaine 
hydrochloride, which is a water-soluble salt and has a molecular weight of 
339.81. About 89% of the commercial product is in the hydrochloride form. 
Cocaine decomposes at high temperatures and melts at 195°C. Cocaine in the 
alkaloid form (free base) is lipid soluble and can be produced by mixing 
cocaine hydrochloride salt with an alkali. The free base is odorless, colorless 
and has a molecular weight of 303.36 (Byck, 1974). 
Cocaine free base ("crack") is more stable on heating, vaporized readily 
and has a very high bioavailability when smoked. Helfrich et al. (1983) 
reported that intranasal cocaine use was most frequent. Schnoll et al. (1985) 
reported that more than 40% of their patients used cocaine in its free base form. 
Gawin and Kleber (1985) reported a similar proportion of intravenous users. 
Another study (Kain et al. 1992) reported that 40% of addicts use cocaine 
intranasally, 30% by free base smoking, 20% by injection and 10% by 
combined use. The different percentages reported by different studies may be 
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related to the time sampled or the geographical area covered by the different 
surveys. 
Cocaine is rapidly absorbed by the mucous membrane. The most rapid 
absorption of cocaine occurs after inhalation of the free base cocaine, with peak 
absorption into the pulmonary circulation and brain in only 8-10 seconds 
(Ellenhorm and Barceloux, 1988). Peak plasma levels after intranasal 
absorption of crystalline cocaine occur approximately 30 min, with 96 mg of 
cocaine resulting in peak plasma level of 150 to 200 ng/ml (Javid et al.，1978). 
The plasma half-life of cocaine in the rat and human is in the range of 40-80 
minutes (Wiggins, 1992). 
Cocaine is metabolized by plasma and liver cholinesterases to 
water-soluble metabolites which will be excreted in the urine (Vitti and Boni, 
1985). Cocaine may be present in the urine of an adult for 24 to 36 hours after 
cocaine administration depending on the route of administration and 
cholinesterase activity. Less than 5% of cocaine is excreted unchanged in urine, 
the rest is metabolized to the three major metabolites, ecgonine methyl ester 
(EME), benzoylecgonine and norcocaine. EME and benzoylecgonine constitute 
over 80% of cocaine metabolites and have a half life of four to six hours (Inaba 
et al.，1978; Kloss et al.，1984; Jatlow, 1987). Norcocaine, though a minor 
metabolite which is N-demethylated from cocaine, is the only cocaine 
metabolite with a significant pharmacologic activity. Hydrolysis by liver and 
plasma esterases plays a major role in the metabolism of cocaine. However, 
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plasma cholinesterase activity is much lower in fetuses, infants, elderly men, 
patients with liver disease, and pregnant women, all of whom would be 
expected to be more sensitive to cocaine (Johanson and Fischman, 1989). 
Cocaine causes many pharmacological, physiological and psychotropic 
effects on human. Most of its known pharmacological actions are related to 
cocaine's local anesthetic and vasoconstrictive properties (Barash, 1977). 
Physiologically, it has a very potent effect on the sympathetic nervous system, 
increasing heart rate and blood pressure (Fischman et al.，1985). The 
psychotropic effects of cocaine occur more rapidly and are associated with 
arousal and euphoria followed by irritability, depression and dysphoria (Van 
Dyke et al., 1976). 
1.2 Maternal Cocaine Abuse 
1.2.1 Human Studies 
1.2.1.1 Prevalence 
In the past decade, there has been a growing health problem due 
to a substantial number of human infants bom each year that are exposed to 
cocaine in utero (Miller, 1983; Chasnoff et al” 1985; Clayton, 1985; Chasnoff 
et al.,1987; Mofenson and Caraccio, 1987; Frank et al., 1988; Little et al.， 
1988; O'Malley et al, 1988; Neerhof et al, 1989; Hume et al.,1989; Chasnoff 
et al., 1990). Approximately 40% of Americans who use cocaine regularly are 
between the ages of 20 and 30，i.e. they are at prime childbearing years 
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(Clayton, 1985; Mofenson and Caraccio, 1987; Abelson and Miller, 1985; 
O'Malley et al., 1991). A 1989 survey of 18 hospitals performed by the Select 
Committee on Children, Youth and Families in the USA (Miller, 1989) 
reported cocaine as the drug of choice in pregnant substance abusers. 
Examination of pregnant women for cocaine use has revealed positive urine 
tests or verbal confirmation ranging from 8 to 46%. These values should be 
viewed in terms of the patient population and methods used to assess 
prevalence. That is, higher rates for cocaine use would be expected in 
inner-city hospitals serving patients of low socio-economic status and in 
facilities using multiple screening methods. 
Drug abusers, in general, engage in polydmg abuse. This is also true for 
the pregnant cocaine user. Some of these substances include nicotine 
(cigarettes), alcohol, opiates (heroin, methadone), marijuana, amphetamines, 
tranquillizers, PCP, and psychodelics. Cocaine withdrawal is associated with a 
number of adverse side effects (e.g., agitation, dysphoria, paranoia). Many 
cocaine users will take other drugs to ameliorate these unpleasant side effects. 
For example, one survey found that 66% of female cocaine addicts drank 
alcohol heavily or used some other drug to "come down" from their "cocaine 
high" (Washton et al.，1984). Thus, cocaine abuse is not only associated with, 
but may even advance the abuse of other drugs. The problems of polydmg 
abuse and toxic adulterants are important considerations because it is often 
difficult to determine if the effects on the mother and the fetus are due to 
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cocaine, some other drug, or an interaction between the two (Church et al.， 
1991a). 
1.2.1.2 Effects of Cocaine on the Developing Fetus 
Due to the lower levels of serum esterases in both the fetal and 
maternal serum during pregnancy, a given dose of cocaine in a pregnant female 
can produce higher and more sustained blood levels of cocaine (Stewart et al., 
1979; Chasnoff et al , 1989a,c,d; Fleming et al , 1990). It had been shown that 
cocaine can cross the placenta rapidly (Chasnoff and Lewis, 1988). The highest 
concentration of cocaine in pregnant women were found in the uterus and 
placenta and that fetal cocaine concentration in the plasma was 1/6 to 1/9 of 
those found in the mother (Mittleman et al, 1989). 
However, it had been shown that cocaine does not directly influence the 
placental vasculature, rather, it enhances placental vasoconstriction by 
increasing the sensitivity of the vasculature to vasoconstrictive agents like 
circulating catecholamine and serotonin (Ellasson and Astrom, 1955; Mahalik 
et al.，1984). This increase in sympathetic tone caused spasm of the uterine 
vessels and result in maternal hypertension, accelerated heart rate (tachycardia) 
and the transient decrease in uterine blood flow (Fischman et al., 1976). These 
effects were suggested to cause an impairment of oxygen and nutrient transfer 
to the fetus (Woods et al., 1987; Vinci et al, 1990). 
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These mechanisms of decreased placental blood flow and compromised 
oxygen associated with maternal hypertension and tachycardia had been 
implicated in the increase number of spontaneous abortion and placental 
abruption in pregnant users; and in the incidence of prematurity, growth 
retardation and birth defects in infants exposed in utero to cocaine (Gingras et 
al.’ 1992). 
1.2.1.2.1 Fetal Mortality 
In a study on 12 cocaine-abusing women (Chasnoff et al. 
1985), it was reported that 38% of their past pregnancies were terminated 
spontaneously. Another study found that 25% of the cocaine-abusing women 
(N=56) had spontaneous abortions occurring between 10 and 20 weeks 
gestation (Hadeed and Siegel, 1989). Frank et al. (1988) similarly reported that 
30% of cocaine users had at least one spontaneous abortion compared to 21% 
of nonusers. In contrast, some studies reported no significant histories of 
spontaneous abortions for pregnant women who abuse cocaine (Bingol et al, 
1987; Ryan et al., 1987; Graham et al.，1990). 
Stillbirth rates were increased among women who continued cocaine use 
till late into the third trimester (Acker et al., 1983; Bingol et al., 1987; Ryan et 
a l , 1987; Cherukuri et al, 1988; Critchley et al.，1988; Eyler et al., 1988; 
Hadeed and Sieget，1989; Little et al., 1989; Neerhof et al , 1989). These 
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studies suggested that the stillbirth rates among cocaine abusing women may be 
five to ten times higher than usual (Church et al , 1991b). 
1.2.1.2.2 Placental Abruption 
An association between placental abruption and maternal 
cocaine abuse was first noted by Acker et al. (1983) and subsequently 
confirmed by numerous other studies. Results from these studies suggested that 
the rate of placental abruption in cocaine-abusing women was about ten times 
higher than in nonusers. One of the recent studies, using 592 pregnant cocaine 
users and 4687 nonusers, supported these findings. The rate of placental 
abruptions doubled from 0.96% in controls to 1.86% in cocaine users 
(Dombrowski et al.，1991). There were a few studies, however, that found no 
association between cocaine use and placental abruptions (MacGregor et al., 
1987; Chouteau et al.，1988; Doberczak et al , 1988). 
1.2.1.2.3 Premature Birth 
Several studies have reported preterm delivery in women 
who abuse cocaine throughout pregnancy (Bingol et al., 1987; Chasnoff et al., 
1987; Oro and Dixon, 1987c; Chenikuri et al.，1988; Chouteau et al , 1988; 
Chasnoff et al., 1989c,d; Collins et al., 1989; Fulroth et al, 1989; Hume et al, 
1989; Kaye et al , 1989; Little et al, 1989; Neerhof et al.，1989; Ostrea et al.， 
1990). The average number of premature births in these studies was 25% of the 
9 
pregnancies of cocaine users in comparison with an 8% rate for nonusers 
(Church et a l , 1991b). Mastrogiaimis et al. (1990) found that premature 
delivery was associated only with the neonates with positive urinary cocaine 
concentrations, suggesting that recent maternal use of the drug precipitates 
labour. 
There are however contrary evidence failing to observe a 
cocaine-associated effect on gestational length (Chasnoff et al., 1985, 1987; 
Madden et al., 1986; Ryan et al , 1987). 
1.2.1.2.4 Neonatal Effects 
Complications at delivery included an increase in 
meconium staining, one sign of fetal distress, in up to 25% of the births to 
cocaine-abusing women, approximately twice the control group rate (see 
Church et al., 1991b for review). 
Many investigators observed intrauterine growth retardation (lUGR) in 
association with prenatal cocaine exposure (see Church at al., 1991b for 
review). The majority of these studies reported reduced birth weights, body 
lengths, and head circumferences in the infants bom to cocaine-abusing 
women. The incidence of lUGR for the exposed infants was about four times 
greater than for control. Increased rates of lUGR were not seen in infants bom 
to women who ceased cocaine use after the first trimester (Chasnoff et al., 
1989c,d). There are also several studies reporting no specific effect of maternal 
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cocaine abuse on fetal growth compared with women abusing other drugs 
(Chasnoff et a l , 1985, 1987, 1988; Frank et al” 1990). A particularly 
interesting observation reported that the birth weights of offspring of women 
abusing cocaine are more normal when the mothers received prenatal care 
(MacGregor et al.，1989). 
1.2.1.3 Congenital Abnormalities 
1.2.1.3.1 Cardiovascular Abnormality 
A comparison of 214 infants who tested positive for 
cocaine metabolites and 314 infants who tested negative indicated the rate of 
central cardiovascular anomalies to be significantly higher in the positive 
infants (Lipshultz et al., 1991). Structural defects among the cocaine positive 
infants included peripheral pulmonic stenosis, patent ductus arteriosus, atrial 
septal defect, ventricular septal defect and prolapse of an aortic valve leaftlet 
(Grabitz et al, 1988). Other altered cardiac functions such as conduction 
defects, voltage abnormalities and transient ventricular tachycardia have also 
been reported in cocaine-exposed infants (Geggel et al., 1989; Lipshultz et al, 
1991). 
Brain haemorrhage in newborns (Chasnoff et al.，1986; Dixon and 
Bejar, 1989; Mercado et al.，1989; Spires et al , 1989) had also been reported. 
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1.2.1.3.2 Genitourinary Tract Malformation 
There had been a number of studies showing a wide 
variety of genitourinary abnormalities in the infants that were exposed to 
cocaine prenatally (see Kain et al , 1992 for review). For example, Chasnoff 
and colleagues (1988) have reported that 9 out of 75 (12%) infants bom to 
cocaine-abusing women had urogenital anomalies. Chavez et al. (1989) 
reported that 276 out of 2835 cocaine-exposed babies studied had urinary tract 
malformations and 761 out of 2973 cocaine-exposed babies studied showed 
genital anomalies. Despite the many reports, the mechanism of genitourinary 
tract deformity remains unknown. 
1.2.1.3.3 Gastrointestinal Abnormality 
Reports of infants exposed to cocaine in utero contain a 
spectrum of developmental anomalies including jejunal atresia, imperforate 
anus with midcolonic atresia, anal atresia, ileal atresia, and widespread 
infarction of the bowel (see Kain et al, 1992 for review). The vasoconstrictor 
effect of cocaine may account for some of these abnormalities. Necrotizing 
enterocolitis (NEC) is a common serious gastrointestinal problem of neonates 
requiring intensive care. NEC was shown to be associated with prenatal 
exposure to cocaine as well (Telsey et al, 1988). This may be due to increased 
mesenteric vascular resistance induced by cocaine resulting in ischemia of the 
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fetal bowel wall and vulnerability of the bowel to bacterial infection thus 
resulting in NEC-like disease and bowel perforation (Rosario et al., 1990). 
1.2.1.3.4 Respiratory Disorders 
A number of reports suggested an association between 
Sudden Infant Death Syndrome (SIDS) and in utero exposure to cocaine (see 
Kain et al., 1992 for review). However, individual case reports are often 
difficult to interpret because of concurrent maternal problems, including the use 
of alcohol, marijuana and other illicit drugs, and deficient prenatal and 
postnatal care. 
An early study concluded that SIDS was the cause of death in 10 out of 
60 infants exposed to cocaine in utero (Chasnoff et al.，1989b). However, 
another study of 32 infants exposed to cocaine failed to identify any case of 
SIDS (Bauchner et al., 1988). A large cohort study which involved 1014 
mother-infant pairs reported that the risk of SIDS was 5.6 in 1000 among 
cocaine-exposed infants, and 1 to 3 in 1000 among the general population 
(Bauchner et al.，1988). A review of all SIDS deaths in the City of New York, 
from 1979 to 1989 found an incidence among exposed infants to be 4.1 in 1000 
versus 1.3 in 1000 in non-exposed infants (rate ratio of 3.1) (Kandall et 
al.，1991). 
Chasnoff et al. (1989b) documented apnea and periodic breathing in 
38% of a group of 32 infants exposed to cocaine in utero. Gibson et al. (1990)， 
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in a prospective study, evaluated the prevalence of apnea in cocaine-exposed 
term and preterm infants. They found that 26% of the cocaine group had 
abnormal breathing patterns, principally central apnea and also periodic 
breathing. 
1.2.1.3.5 Visual and Hearing Disorders 
Abnormalities of the eye and vision have been noted in 
infants exposed to cocaine in utero. One study noted dilated and tortuous iris 
vessels in 6 out of 13 cocaine-intoxicated neonates (Isenberg et al., 1987). 
Retinopathy was also described in an immature infant exposed to cocaine in 
utero without other known risk factors for the retinal pathology (Teske and 
Trese, 1987). Cocaine caused maternal hypertension and fetal hypoxia, which 
may be one mechanism for cocaine-induced effects on the fetal eye. Changes in 
iris vessels had been reported as a third trimester consequence of maternal 
hypertension (Ricci and Molle, 1987). 
Evaluation of the peripheral auditory nervous system of infants exposed 
to cocaine in utero showed a particular vulnerability of infants bom less than 
30 weeks of gestation to peripheral auditory dysfunction (Bierman-Van et al, 
1981). Abnormal brain stem auditory evoked potential have also been reported 
to occur in cocaine-exposed infants (Shih et al, 1988). Two recent reports 
suggested that the effect on the auditory system was mediated by the secondary 
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asphyxia, low birth weight and/or CNS injury induced by cocaine (Carzoli et 
al., 1990; Schwartz et a l , 1990). 
1.2.1.3.6 CNS and Behavioural Abnormalities 
The central nervous system is one of the first organ 
systems to develop in the early embryo and one of the last to reach maturity 
postnatally (reviewed by Wiggins 1986). Hence it is highly vulnerable to 
perturbation during its long development and any departure from the normal 
course of brain development would have important consequences. Over the past 
few years several groups have reported a number of CNS complications in 
infants exposed to cocaine in utero (see Kain et al.，1992 for review). For 
example, small head circumference, an index of brain size, has been one of the 
more commonly reported anomalies in neonates (Mahalik et al , 1984; 
Chasnoff et al., 1989c,d). One study found cystic lesions, atrophy, and brain 
edema in several infants prenatally exposed to cocaine or methamphetamine 
(Dixon and Bejar, 1989), while cerebral infarcts/intracranial hemorrhages in 
cocaine-exposed neonates have been reported by several human studies (see 
Church et al., 1991a for review). 
Behavioural differences have been noted in human studies (Chasnoff et 
al., 1989a), even in the absence of retarded brain growth or small head size. 
Thus, functional maturation of the brain may be more vulnerable to cocaine 
exposure than simple growth in cell numbers and size. Chasnoff et al. (1985) 
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noted increased tremulousness, deficient interactive behavior and disturbed 
state organization among cocaine exposed infants. Oro and Dixon (1987) 
described a neurologic behavioral pattern typical of infants bom to addicted 
mothers, this include sleep pattern disturbances, tremors, feeding difficulties, 
hypotonia, vomiting, sneezing, high pitch cry and hyperreflexia. Other 
investigators have also described jitteriness, irritability, poor feeding, increased 
muscle tone，impaired motor ability, seizures, apathy and decreased orientation 
(Chasnoff et a l , 1985; Madden et al, 1986; Doberczak et al.,1988; Burkett et 
al.,1990; Petitt and Coleman, 1990; Van de Bor et al., 1990). 
Disturbed state organization was signalled by hyperresponsiveness and 
by difficulty in arousal was also reported (Hume et al., 1989). These 
characteristics were termed "all or nothing", i.e., difficult to arouse and 
inconsolable when aroused with only brief or no periods of quiescence. 
It had also been shown that fetal and neonatal behavioral abnormalities 
were present even if exposure was limited to the first trimester (Petitt and 
Coleman. 1990). 
However，contrary to the above reports, there are studies revealing that 
cocaine-exposed infants had little (Neuspiel et al., 1991) or no neurobehavioral 
dysfunction (Schneider et al.，1989; Eisen et al, 1991; Richardson and Day, 
1991; Coles et al , 1992). 
Transient behavioral effects to cocaine exposure have also been 
suggested by three studies. In one study, newborn tremulousness, irritability 
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and muscular rigidity were present in the newborn period compared to controls 
but resolved by 3 to 3.5 months of age (Chasnoff et al., 1989a). In another 
human study (Doberczak et al., 1988), abnormal EEG and behavioral findings 
appeared to be normalized between 3 and 12 months of age. The third study 
(Salamy et al.，1990) reported increased brainstem transmission times in 
neonates and young infants exposed to cocaine suggesting altered myelination. 
The abnormalities appeared to resolve by 1 year of life. 
Longer term follow-up is necessary to determine the full developmental 
impact of intrauterine cocaine exposure. While "clusters of abnormal signs" on 
neonatal neurological examinations may be indicative of later developmental 
problems, neonatal neurological examinations are also known for their high rate 
of "false positives." It is also possible that the nervous system may develop 
compensatory mechanisms and that signs of dysfunction may not be detectable 
at the time of follow-up (Bierman-Van et al.，1981; Prechtl，1982). 
1.2.2 Animal Studies 
In order to study the mode of action of prenatal cocaine exposure on the 
infants, animal models using pregnant rat, mice, sheep, baboons, monkey, 
guinea pig and rabbit were established. Different cocaine concentrations, routes 
of administration and duration of cocaine-exposure (prenatal and / or postnatal 
exposure) were used to study the various physiological, behavioral and 
neurochemical effects of cocaine on the offspring. This is due to the specific 
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causality by cocaine on outcome in the human being difficult to ascertain 
because of multiple confounding variables associated with substance abuse 
including social factors and polydrug use as well as difficulty in confirming 
timing, dose and frequency of cocaine exposure. As a result the many animal 
studies were developed to further understand the direct developmental effects 
of cocaine exposure in utero and where many of these confounding variables 
can be controlled. 
1.2.2.1 Routes of Administration, Dosage and Tissue 
Distribution 
There are several studies comparing the administration routes in 
the rat model. Comparison include oral vs subcutaneous (Dow-Edwards et al.， 
1989a), intravenous vs intranasal (Javid et al., 1983; Jeffcoat et al.，1989), 
intravenous vs oral (Wiggins et al , 1989) and intranasal vs oral (Wilkinson et 
al., 1980; Van Dyke et al.，1978). For example, it was shown that oral 
absorption appears to be substantially faster than after subcutaneous delivery. 
The oral route resulted in dose-response relationships with several behavioral 
changes observed and demonstrated a lack of gastrointestinal pathology 
(Dow-Edwards et al., 1989a,b). 
Comparison of nasal and oral administration showed that peak plasma 
concentrations of cocaine after nasal delivery were reached only slightly faster 
then (Wilkinson et al., 1980) or at nearly the same time as (Van Dyke et al, 
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1978) those after oral administration suggesting there were no specific 
advantages in the nasal administration compared to the oral one. 
It was reported that the oral route is preferred compared to the 
intraperitoneal route in order to avoid direct risk to the uterus (Fantel and 
MacPhail, 1982). Subcutaneous routes results in slow uptake of cocaine and 
also in skin necrosis in the injection region (Dow-Edwards et al , 1989a). 
Intravenous delivery is not practical as a daily procedure. Similarly, the nasal 
route is a difficult procedure and offers poor control of dosage (Wiggins, 
1992). 
Dose-dependent effect of cocaine on the pregnancy outcome were 
investigated using a cocaine concentration of 40-90 mg/kg cocaine 
hydrochloride from gestation day 7 to term (Church et al., 1988). Results 
showed that there was a dose-dependent effect on maternal weight gain, 
maternal food and water consumption, fetal weight, maternal and fetal 
fatalities, fetal edema, placental abruption and cephalic hemorrhages with the 
threshold for such fetal lethality and behavioral teratology to be 60 mg/kg/day. 
It had also been reported that animals receiving 80 mg/kg/day by oral 
intubation exhibited seizures (Dow-Edwards et al., 1989a). Dose-dependent 
studies using doses from 10 mg/kg, a dose sufficient to produce 
self-adminstration in rats (Pickens and Thompson, 1968), 20 and 40 mg/kg 
showed little effect on litte size, birth weights, development or physical 
changes in the offspring (Spear et al., 1989c). Result from these studies 
19 
suggested that the effect dose of cocaine to illicit behavioral changes without 
lethality to be in the range of 40-60 mg/kg/day. Previous reports have also 
documented seizures and death within this dose range following multiple 
cocaine injections (Bozarth and Wise, 1981). A single administration of 
cocaine of this dose range did not result in seizure or death, whereas multiple 
dose resulted in sensitization to a convulsive end point (Dow-Edwards et al., 
1989a). 
De Vane et al. (1989) reported the half-life of cocaine in the rat maternal 
plasma and fetus to be 46 and 55 minutes respectively, similar to values 
reported for cocaine elimination half-life in human plasma. They also showed 
that the order of cocaine concentration was placenta > fetal liver > maternal 
heart > whole fetus > fetal brain > maternal brain = maternal plasma. The level 
of norcocaine, one of the cocaine metabolites, concentration in fetal and 
maternal brain were shown to be 6% and 20% respectively relative to the 
cocaine concentrations in plasma and tissue (De Vane et al.，1989). While the 
other cocaine metabolite, benzoylecgonine is largely excluded from the adult 
brain (Wiggins et al , 1989)，the fetal brain has no blood-brain barrier and 
concentrations of this metabolite in the fetal rat brain are higher than in the 
maternal brain (Spear et al., 1989b). The effects of the cocaine metabolites may 
also be another factor implicated in the effects of cocaine in brain development. 
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1.2.2.2 Maternal and Offspring Effects 
Animal studies, like that of human studies reported, showed that 
cocaine has potent effects on the placenta. Cocaine crosses the placenta by 
simple diffusion (Shah et al , 1978; Moore et al , 1986; Mofenson and 
Caraccio, 1987) and is concentrated within the fetal/embryonic milieu (Mule et 
al.，1976; Shah et al.，1978; Farrar and Keams, 1989) achieving peak levels in 
the fetal circulation by 3 min (Stewart et al., 1979; Woods et al , 1987，1989). 
Cocaine administered to pregnant baboons (Morgan et al , 1991) and sheep 
(Moore et al., 1986 ； Woods et al., 1987) showed intense vasoconstriction in 
the uterine arteries. Moore et al. (1986) found that maternal and fetal blood 
pressures in the pregnant sheep were elevated within 5 min after cocaine 
infusion and uterine blood flow (UBF) declined an average of 36 to 42%. 
Maternal blood pressure returned to normal within 10 min while UBF took 
twice as long to normalize. The maternal cardiovascular effects were due in 
part to increased norepinephrine levels. The effects of cocaine on blood 
pressure and UBF in the pregnant sheep were confirmed by Woods et al. (1987， 
1989). These authors also evaluated fetal oxygenation, which like UBF, was 
transiently reduced following cocaine treatment. 
In another recent study on pregnant sheep it was shown that cocaine 
administration caused a dose-depentent increase in maternal blood pressure and 
heart rate and in fetal blood pressure, and a decrease in fetal arterial oxygen 
tension. In the ewe, blood pressure changes corresponded linearly to dose 
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administered. Blood pressure changes were correlated to peak plasma cocaine 
concentration in the ewe and in the fetus (Burchfield et al , 1991). Thus, this 
decrease in uterine blood flow, increased in fetal and maternal blood pressure 
and heart rate and the compromised oxygen delivery to the fetus could result in 
altered fetal somatic and fetal brain development. 
1.2.2.2.1 Fetal and Maternal Mortality 
Fetal mortality had not been observed by investigators 
using a range of cocaine dosages sublethal to rat dams [0 to 60 mg/kg/day] 
(Hutchings et a l , 1989; Spear et al., 1989a; Wiggins and Ruiz 1990a，b) and 
increased rates of spontaneous abortion were not indicated in the experimental 
literature. Stillbirths have occurred after dosages greater than 70 mg/kg/day 
(Church et al.，1988). It was shown that there was an increase in maternal 
mortality with an increase in the cocaine dose in Long-Evan rats exposed to 
40-100 mg/kg/day (Church et al.，1988, 1990b,c). These studies showed that 60 
mg/kg/day was the threshold for maternal lethality. The maternal fatalities were 
suggested to be due to cocaine-induced seizures or respiratory depression at 
high dosages (Church et al, 1990b,c). 
1.2.2.2.2 Gestational Length 
Cocaine treatment, despite the toxic dose of 100 
mg/kg/day, did not cause any change in gestational length (Church et al., 
22 
1990b，c). These observations are contrary to a segment of the human literature 
suggesting that premature birth is a sequela of cocaine use during pregnancy 
(see section 1.2.1.2.3). It is possible that the rat is different from humans in this 
regard. It is also possible that the incidences of premature birth reported in the 
human literature were misattributed to cocaine abuse and were really associated 
with teenage pregnancy, abuse of other drugs, or some other risk factor. 
Contrary evidence has also been provided by several human studies failing to 
observe a cocaine-associated effect on gestational length (Chasnoff et al., 1985, 
1987; Madden et a l , 1986; Ryan et al., 1987). 
1.2.2.2.3 Maternal Weight Gain and Fetal Weight 
Maternal weight gain determined by the change in weight 
from gestational day 7 to 21 (the day when several dams starting birthing) 
showed that there was progressively less maternal weight gain with increasing 
cocaine dose (40-100 mg/kg/day) (Church et al , 1988，1990c). Other studies 
using cocaine doses below 60 mg/kg/day showed no significant change in 
maternal weight gain (Dow-Edwards, 1989b). Fetal exposure to sublethal 
dosages of cocaine did not cause any significant lag in rat birth weights 
(Church et a l , Spear et al” 1989c; 1988; Sobrian et al.，1990; Wiggins and 
Ruiz 1990a). Growth retardation at high dosages is not meaningful, since these 
dosages tend to result in high rates of fetal and maternal morbidity and 
mortality (Church et al, 1990c; Wiggins and Ruiz, 1990a). In contrast to fetal 
23 
growth, postnatal growth in rats is retarded when cocaine is administered to 
lactating dams (Church et al., 1990c; Wiggins and Ruiz, 1990a) 
1.2.2.2.4 Little Size 
Litter size was based on both the number of live births and 
stillbirths. There was no change in litter size and male, female sex ratio 
reported in the majority of the animal studies except that which was reported 
by Church et al., (1990c) where there was a significant reduction in the litter 
size when the dams were exposed to high doses of 100 mg/kg/day cocaine. 
1.2.2.3 Congenital Abnormalities 
In an attempt to reproduce structural teratogenesis in an 
experimental animal model Mahalik et al.，(1980, 1984) designed treatment 
paradigms to examine critical periods of susceptibility to cocaine exposure. The 
abnormalities detected in fetal mice paralleled the period of ontogenesis for 
these structures and support a direct teratogenic property for cocaine. For 
example, neural tube defects hydronephrosis，cryptorchidism, as well as a 
variety of skeletal anomalies, including malformation and delayed ossification 
of stemomanubrium, the xyphoid process, ribs and paws were observed. Other 
malformations found included malformed lenses, anopthalmia and 
micropthalmia (Mahalik et al., 1980, 1984). Other changes in the genitourinary 
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system include a size reduction in the seminal vesicles of prenatal 
cocaine-exposed rats, but no change in testicular size (Church et al., 1991a). 
The recent studies by Church et al., (1988, 1991c) in the Long-Evans 
rat, by Finnell et al., (1990) in two strains of mice and by Webster and 
Brown-Woodman (1990) in the Sprague-Dawley rats all reported increases in 
the incidence of cardiovascular malformations in pups exposed to cocaine 
prenatally. Other studies on cardiovascular anomalies included an increase on 
the incidence of cephalic hemorrhages with dosage higher than 60 mg/kg/day 
(Church et al.，1988; Wiggins and Ruizb, 1990b; el-Bizri et al., 1991) as well 
as pulmonary stenosis transposition of the great arteries and hemopericardium 
(Finnell et al.，1990). 
Changes in the respiratory system was shown by Kain et al. (1991) 
where cocaine enhanced production of pulmonary surfactant. In this study on 
prenatal cocaine-exposed rabbits, an increased lung distensibiltiy and stability 
as a result of accelerated morphologic maturation and enhanced surfactant 
function was shown. 
It had also been shown that prenatal cocaine exposure in the rat result in 
delayed external ear maturation (Church et al, 1990a). More importantly, the 
rat's brainstem auditory evoked potential (BAEP) showed evidence of 
recruitment-type sensorineural hearing loss (Church and Overbeck, 1991c). 
Abnormal BAEPs have also been observed in cocaine-exposed infants (see 
section 1.2.1.3.5). While this human study did not investigate the possibility of 
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hearing loss per se, abnormal BAEPs imply compromised auditory function. 
Various other studies have reported increased acoustic startle responses in 
cocaine-exposed neonates (see section 1.2.1.3.6) and altered metabolic activity 
in subcortical auditory nuclei of rats postnatally exposed to cocaine 
(Dow-Edwards et al., 1988). 
1.2.2.4 Behavioral Changes 
Many studies including age-dependent, dose-dependent and 
different administration routes have reported developmental delays and 
behavioral maturation in the cocaine exposed rat offspring (Hutchings et al., 
1989; Smith et al., 1989; Spear et al., 1989a; Church et al.，1990a，b; Henderson 
and McMillen, 1990). 
Animal studies of prenatal cocaine exposure also provided evidence of 
postnatal age-dependent behavioral changes such as an increase or decrease in 
locomotor activity. Henderson and McMillen (1990) showed that 
cocaine-exposed rats pups had significantly greater spontaneous locomotor 
activity at 30 days postnatal (PN) than saline control pups. Spear and 
coworkers (1989b) observed enhanced locomotor activity at PN 12 days in the 
rats exposed to cocaine prenatally. Hutchings et al. (1989) examined the 
activity of whole litters with a capacitance sensing device in one hour sessions 
at three day intervals from PD 2 through PD 32. The litters that had been 
exposed to cocaine produced more counts than control group on PD 20 and PD 
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23. Church and Overbeck (199b) however found hypoactivity in rat pups at PN 
20 when exposed to 40 and 50 mg/kg/day of cocaine. Johns et al. (1992a，b) 
also reported that the hypoactivity persisted until PN 49 day in the prenatal 
cocaine-exposed (100 mg/kg/day) rats. The hypoactivity was however not 
present at PN 80-90. 
Apart from change in locomotor activity, hyper-responsiveness to stress 
(Smith et al., 1989; Spear et al , 1989a; McMillen et al., 1991; Johns et al., 
1992b; Bilitzke and Church, 1992), delayed or accelerated acquisition of the 
righting reflex (Henderson and McMillen, 1990; Sobrian et al., 1990) and 
accelerated development in acoustic startle response (Davis, 1985; Sobrian et 
al.，1990) were also reported. Fetal behavioral changes were also observed 
(Burchfield et a l , 1990; Abrams et al , 1992) as shown in the decrease in rapid 
eye movement and non-rapid eye movement sleep (Abrams et al., 1992). 
There are however, like the human studies, contrary reports to these 
animal studies revealing little or no behavioral changes in the prenatally 
cocaine-exposed animals. These contrary studies showed no pronounced 
changes in exploratory behavior and activity (Riley and Foss，1991)，acoustic 
startle reflex (Foss and Riley, 1991) and conditioned place preference (Heyser 
et al.，1992). 
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1.2.2.5 Neurochemical Changes 
It is known that cocaine has several sites of action in the adult 
central nervous system. Cocaine has been shown to block the reuptake of 
dopamine (DA), norepinephrine (NE) and serotonin (5-HT) (see Carroll et al , 
1992a，b)，and the cocaine binding site on the DA transporter has been 
implicated in the reinforcing and addicting properties of cocaine (Ritz et al, 
1987; Kuhar et al.，1991). Although the pharmacological effects of 
cocaine-abuse in the adult is well documented (see Johanson and Fischman, 
1989; Koob，1992 for review), there are however, only few studies reporting on 
the neurochemical changes in the offspring resulting from prenatal cocaine 
exposure. 
1.2.2.5.1 Glucose Metabolism 
Dow-Edwards et al. (1988) have found significant 
increases in glucose metabolic activity in the limbic, sensory, and motor 
systems of the PN 60 days old cocaine-exposed rat brain using quantitative 
autoradiography. It is of interest that only minimal alterations were found in the 
male offspring, while substantial increases were found in the female offspring. 
Burchfield and Abrams (1993) had shown that cocaine resulted in a generalized 
decrease in local cerebral glucose utilization and a specific increase in glucose 
utilization in parts of cortical white matter of the frontal gyri in the fetal sheep 
at 125 days gestation. 
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1.2.2.5.2 Dopamine Transporter 
Byrnes et al. (1993) reported that dopamine transporter 
binding in striatum was significantly reduced at 6 weeks old cocaine-exposed 
mice when compared to controls. Koff and Miller (1994) showed that the 
dopamine transporter binding in striatum was significantly increased at 3 and 6 
months old cocaine-exposed mice when compared to control group. The 
authors in these two studies measured the effects of prenatal cocaine using an 
unconventional in vivo method. 2 jiCi [^H]WIN 35428 was injected to prenatal 
cocaine-exposed mice or control group via the tail vein, and the striatum was 
solubilized for total binding and the cerebellum was solubilized for 
non-specific binding after 30 minutes. The specific binding was defined as 
striatal dpm/weight (total) minus cerebellar dpm/weight (nonspecific). 
However, this method seems rather crude in measuring the dopamine 
transporter binding. Scatchard analysis would be more accurate where the 
number of receptor sites ( B ^ and the binding affinity (K) can be established. 
Also, results expressed in concentration of radioactive-labelled ligand/mg 
protein would be a more accurate estimate than dpm/tissue weight as presented 
in these two studies. 
1.2.2.5.3 Dopamine D^  Receptor 
A number of animal studies on prenatal cocaine exposure 
have shown changes in the dopamine receptors although the findings have been 
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inconsistent. It had been shown autoradiographically that at postnatal day 
(PND) 11 and 20 there is an increase in D^ dopamine receptor binding in the 
striatum (Dow-Edwards, 1989b) as well as in the substantia nigra at PND 60 of 
the cocaine-exposed offspring (Dow-Edwards et al.，1990). This change in D^ 
dopamine receptor was however not observed at PND 21 in the striatum and 
nucleus accumbens using Scatchard analysis (Scalzo et al., 1990). 
1.2.2.5.4 Dopamine D: Receptor 
Changes in the dopamine D: receptor included a decrease 
in the K^ of the dopamine D^ receptor in the striatum at PND 21 (Scalzo et al., 
1990) and a decrease in B腿 in the striatum at PND 18 (Henderson et al.， 
1991). However, contrary evidence was also observed showing no change in D^ 
receptor binding at PND 14 (Fung et al.，1989). 
1.2.2.5.5 Tyrosine Hydroxylase 
Tyrosine hydroxylase is a rate-limiting enzyme of 
dopamine. Akbari and Azmitia (1992) showed that an increase in tyrosine 
hydroxylase immunostained catecholamine fibers were observed in the 
hippocampus, anterior cingulate cortex, and parietal cortex in PND 28, 40 
mg/kg/day cocaine-exposed rats. Meyer and Dupont, (1993) reported that 
subcutaneous injection (s.c.) of pregnant rats with 40 mg/kg of cocaine daily 
from gestational day (GD) 8 to GD 20 resulted in an 8.7% stimulation of fetal 
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whole-brain TH activity when compared to controls. Rats implanted 
subcutaneously with Silastic capsules filled with 80 mg of cocaine on GD 18 
showed a 28% increase in fetal TH activity measured 3 days later on GD 21 
(Meyer and Dupont, 1993). 
1.2.2.5.6 Other Changes 
Anderson-Brown et al. (1990) showed that injection of 
neonatal rats given an acute cocaine at PN 1-15 days resulted in a transient 
inhibition of [^HJthymidine-labelled DNA synthesis in the developing brain. 
With chronic cocaine administration, the cerebellum displayed a pronounced 
rebound elevation of DNA synthesis 24h after the last dose suggesting a 
delayed cell maturation process caused by chronic-cocaine exposure. 
Lien et al. (1994) studied the effect of cocaine on brain cell membrane 
structure and function in the fetal guinea pig. This study showed that acute fetal 
cocaine exposure resulted in a significant decrease in Na+，K+-ATPase activity 
without a significant increase in the products of lipid peroxidation. 
1.3 The Aim of the Study 
Due to the multiple confounding variables like polydrug use and social 
factors associated with maternal cocaine abuse, many animal models had been 
established in order to study the specific mode of action of cocaine prenatally. 
Neurochemical changes observed to date seemed to point to postnatal changes 
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in the dopaminergic system of the offspring resulting from prenatal cocaine 
exposure. However, despite the many behavioral and neurochemical changes 
observed, these findings had been inconsistent (see 1.2.2.4 and 1.2.2.5). The 
discrepancies in the results observed may be due to the difference in drug 
dosage or treatment regimen or the method of analysis. The differences in the 
age of the subject studied could be a crucial factor which makes interpretation 
difficult as this may undermine any transient effects of cocaine not observed in 
fixed time point studies like those reported so far . 
Therefore, this study aims to further determine the effects of prenatal 
cocaine exposure in the dopaminergic system in a long term study from 
postnatal (PN) 0 to 32 weeks. This in order to ascertain whether there are 
transient or long term effects in prenatal cocaine exposure. 
Firstly, at PN 0，1，2，3，4，8, 12 and 32 weeks, rat striatum from the 
offspring exposed to cocaine prenatally was analysed for changes in dopamine 
transporter (DAT), dopamine D^ and D: receptors. Receptor binding assays and 
Scatchard analysis were used to assess the biochemical changes of DAT, D^ 
and D2 receptors. 
Secondly, it was shown that dopamine Dj and D: receptors belong to 
two different groups of dopamine receptors with distinct pharmacological 
functions and district patterns of gene expression (see O'Dowd, 1993). 
Furthermore, repeated cocaine administration in adults showed that there are 
regional differences in the change of mRNA levels for the DAT, D^ and D^ 
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receptors (Laurier et al.，1994; Cerruti et al., 1994). As a result, the change in 
the levels of gene expression of DAT and D�receptor (D! receptor cDNA not 
available) in the prenatal cocaine-exposed offspring were also studied using 
Northern blot analysis and in situ hybridization at PN 0，1, 2, 3，4, 12 and 32 
weeks. 
Thirdly, tyrosine hydroxylase (TH), a catecholamine rate-limiting 
enyzme, was used to determine the morphological changes in the regions 
containing dopaminergic neurons in the brain at PN 0, 1, 2，3, 4，12 and 32 
weeks. 
It is hoped that results from this prenatal cocaine exposure study will 
provide further information on the short or long term changes in the 
dopaminergic system of the offspring at a biochemical, morphological and 
molecular level. 
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CHAPTER II ： MATERIALS AND METHOD 
2.1 Administration of Cocaine 
Female Sprague-Dawley rats (supplied by the animal house of the 
Medical Faculty, Chinese University of Hong Kong) were used in all the 
experiments. Animals were housed in stainless steel cages on a 12 hours 
light/dark cycle with free access to food and water. The animals were mated 
with males of the same strain and the morning when a sperm plug was found 
was designated gestational day 1. The pregnant dams were randomly assigned 
to two treatment groups : cocaine-exposed and control. Rats were dosed once 
each day by oral intubation at 9:00 - 9:30 am with 60 mg/kg/day cocaine 
hydrochloride (May & Baker，MW二339.81) for the cocaine-exposed group and 
the control animals received an equivalent volume of water. 60 mg/kg/day of 
cocaine was chosen for all the experiments because results from previous 
studies showed that cocaine, in the range of 40-60 mg/kg/day, can illicit 
behavorial changes without causing fetal lethality (see section 1.2.2.1). 
The day of delivery is designated postnatal (PN) day/week 0. Following 
delivery, both dames and pups were weighed, the mean maternal weight gain is 
measured as the difference in weight at gestational day 7 and before delivery. 
Pups from each litter were culled to 8-10 pups, keeping to a sex ratio as equal 
as possible. Pups from the cocaine group were not fostered to non-treated 
dams; their mothers did not receive any further cocaine treatment after the day 
of delivery. Cross-fostering was not used in order to approximate the human 
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condition. Furthermore, the plasma half-life of cocaine in the rat and human is 
in the range of 40-80 min (Wiggins, 1992)，which would produce minimal 
residual effects and thus would be expected to be rapidly cleared from the 
mother's body. Pups were weaned at PN day 28 and housed in separate cages 
until the time period required for the studies. 
2.2 Biochemical Studies 
On PN 0, 1, 2, 3，4, 8，12 and 32 weeks, for each treatment group, 2-35 animals 
were selected at random and sacrificed by decapitation. The number of animals 
sacrificed was dependent on the quantity of tissue needed for the binding 
assays for the different ages. Thus at PN 0 weeks, a maximum of 35 brains 
were obtained from each treatment group for one binding assay whereas at PN 
32 weeks, 2 brains were sufficient for one binding assasy. A total of 957 pups 
for each of the two treatment groups were used for the dopamine transporter 
(DAT), dopamine (DA) D^ and D! receptor binding studies. The binding assay 
for each time course and each treatment was done in triplicate. The binding 
assays were repeated three times for the DAT and D�receptor and twice for 
the Di receptor, the offspring of each repeated assay were from different 
pregnant dams. The striatum, where the DAT, D^ and D^ receptors were 
localized, was used for all the biochemical studies. The striatum was isolated 
according to a procedures by Robertson et al., (1989). Preliminary studies on 
the striatum, frontal cortex, hippocampus, brainstem, hypothalamus and 
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cerebellum showed that only the striatum revealed changes in receptor binding 
(data not shown), as a result, only the striatum was chosen for detailed 
biochemical studies. 
2.2.1 Receptor Binding Assays 
The striatum from the cocaine-exposed and control pups were removed 
and dissected on ice. Brain samples from each region were weighed, pooled 
and homogenized with 40 volume of ice-cold 50 mM Tris-HCl buffer with 120 
mM NaCl and 5 mM KCl (pH 7.4) in a glass-Teflon homogenizer (setting 6, 
15s). The homogenate was centrifuged at 50,000 x g (Beckman, Model J2-21 
centrifuge) for 10 min and the resulting pellets washed twice. The final pellets 
were rapidly frozen on dry ice and stored at -70°C until assayed，usually within 
2 weeks of initial homogenization. On the day when binding assays were 
performed, samples were thawed at 4 � C and resuspened in 10 volume of 50 
mM Tris-HCl buffer. Specific binding for DAT, Dj receptor and D^ receptor 
were determined. Scatchard analysis were performed in order to estimiate the 
dissociation constant (KJ and the number of binding sites (B J，K^ and B腿 
values were determined from the data using the non-linear computer curve 
fitting program LIGAND (Munson and Rodbard, 1980) obtained from Dr. P. 
Munson, Bethesda USA. After the specific time, temperature and 
concentrations for DAT, D! and D^ receptors ligand were determined (see 
section 2.2.1.1, 2.2.1.2，2.2.1.3)，the samples were then filtered rapidly through 
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Whatman GF/B filters with a Brandel Cell Harvester followed by washing of 
the filters (3 x 5 ml cold Tris-HCl buffer, pH 7.4). The filters were immersed 
into 3 ml scintillant and extracted overnight, the radioactivity was quantitated 
in a Beckman LSI801 liquid scintillation counter at 48% efficiency. Aliquots 
of membrane preparations were used for the determination of protein content 
by the method of Lowry (1951) with bovine serum albumin as the standard. 
2.2.1.1 Dopamine Transporter 
阳]mazindol (23.5 Ci/mmol, Dupont-New England Nuclear, 
Boston, MA) was used to determine the specific binding and Scatchard analysis 
of dopamine transporter (Javitch et al , 1984; Ritz et al , 1987) in the striatum. 
[^H]mazindol had been shown to bind with high affinity to DA uptake sites in 
striatal membranes and to norepinephrine (NE) uptake sites in cerebral cortex 
and salivary glands (Javitch et al., 1984). 
2.2.1.1.1 Specific Binding Assay and Scatchard 
Analysis 
15 pM nomifensine (Research Biochemicals Incorporated, 
MA. MW=354.4), another DAT blocker, and 6.25 nM [^Hjmazindol was 
selected to define specific binding. The specific binding can be calculated by 
subtracting the non-specific from the total binding and expressed as percentage 
of total bound (specific bound / total bound x 100 %). The concentrations for 
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nomifensine and [^H]mazindol used in this study were according to the 
association and the competition values of Ritz et al , (1988). 
For Scatchard analysis (Scatchard, 1949), concentrations 1.56, 3.125, 
6.25，12.5，25 and 33 nM of [^H]mazindol were used and 15 ^M nomifensine 
was added and incubated at 4°C for 30 min. 
2.2.1.2 Dopamine Dj Receptor 
[^H]SCH 23390 (82 Ci/mmol, Amersham Life Science, England), 
a Dj receptor antagonist, was used to determine the specific binding and 
Scatchard analysis for the dopamine D! receptor (Billard et al , 1984; Hess et 
al.，1986) in the striatum. 10 jxM flupenthixol (Research Biochemicals 
Incorporated, MA. MW=507.5), another D! receptor antagonist, was used to 
define the specific binding. 
2.2.1.2.1 Association Curve 
In order to estimate the time required for equilibrium 
binding to be reached under 1 nM concentration of [^H]SCH 23390 in 1-1.5 
mg/ml striatal membrane, the association curve was established. Normal adult 
rat striatum were assayed using 1 nM ['H]SCH 23390 and 10 i^M flupenthixol 
and incubated at room temperature at 0，30, 60, 90 and 120 min. 
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2.2.1.2.2 Competition Assay 
In this experiment, the ability of dopamine Dj receptor 
antagonist, flupenthixol, to compete with 1 nM [^H]SCH 23390 binding was 
determined. Normal adult rat striatum were assayed at room temperature with 
varying flupentixol concentrations (M) of 1x10"^ 1x10.5，ixlO"^ IxlO", 1x10'^ 
3x10-9，1x10-9，3x10, IxlO-iOand SxlO�together with 1 nM [^H]SCH 23390. 
2.2.1.2.3 Specific Binding Assay and Scatchard 
Analysis 
Based on the results from the association and competition 
assays (see Results section 3.2.3.1, 3.2.3.2), 5 pM flupenthixol, 1 nM [^H]SCH 
23390 and 2 hours incubation time were selected for specific binding and 
Scatchard analysis studies. 
For Scatchard analysis, the striatum from control and cocaine-exposed 
offspring were incubated at room temperature with 0.156, 0.3125, 0.625, 1.25, 
2.5 and 5 nM pH]SCH 23390 and 5 i^M flupenthixol for 2 hours. 
2.2.1.3 Dopamine D: Receptor 
[^H](-)-sulpiride ([^H]sulpiride; 65.2 Ci/mmol, Dupont-New 
England Nuclear, Boston, MA), a D: receptor antagonist, was used to 
determine the specific binding and Scatchard analysis in the striatum. 
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S(-)-sulpiride (Research Biochemicals Incorporated, MA. MW=341.4), another 
D2 receptor antagonist, was used to define specific binding. 
2.2.1.3.1 Association Curve 
In order to estimate the time required for equilibrium 
binding to be reached under 1 nM concentration of [^H] sulpiride in 1 � 1 . 5 
mg/ml striatal membrane, the association curve was established. Normal adult 
rat striatum were assayed using 1 nM [^H]sulpiride and 25 pM s(-)-sulpiride 
and incubated at room temperature at 0, 30，60，90 and 240 min. 
2.2.1.3.2 Competition Assay 
The ability of dopamine D: receptor antagonist, 
s(-)-sulpiride, to compete with 1 nM [^H]sulpiride binding was determined. 
Normal adult rat striatum were assayed at room temperature with varying 
s(-)-sulpiride concentrations (M) of IxlO"^ I x l O � 1 x 1 0么 IxlO"^, 1x10^ 
3x10-9，1x10-9, 3x10-10, ixlO-10 and 3x10-11，together with 1 nM [^H]sulpiride. 
2.2.1.3.3 Specific Binding Assay and Scatchard 
Analysis 
Based on the results from the association and competition 
assays (see Results sections 3.2.4.1，3.2.4.2)，10 pM s(-)-sulpiride and 1 nM 
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['H]sulpiride and 90 minutes incubation time were selected for specific binding 
and Scatchard analysis studies. 
For Scatchard analysis, the striatum from control and cocaine-exposed 
offspring were incubated at room temperature with 0.156，0.3125，0.625, 1.25， 
2.5，5, 10 and 20 nM [^H]sulpiride and 10 |iiM s(-)-sulpiride for 90 minutes. 
2.2.1.4 Assay for Residual Cocaine in Maternal Brain 
All pups from the cocaine-exposed group were not fostered to 
non-treated dams after delivery and their mothers did not receive any further 
cocaine treatment. In order to examine whether transporter or receptor changes 
in the offspring at PN 0 weeks may be due to the amount of residual cocaine 
present in the mother, the residual cocaine in the maternal brain were assayed. 
Due to the limited availability of facilities, maternal brain rather than breast 
milk was assayed for the presence of maternal residual cocaine. 
To assay for the presence of maternal residual cocaine in the brain, 
maternal striatal tissues were obtained at 0 (n = 4)，3 (n = 2) , 7 (n = 2) and 14 
(n 二 2) day after delivery [day 0 of delivery was defined as two to three hours 
after delivery (AD)]. Specific binding assays were used to assess the presence 
of residual cocaine. 5 nM pH]mazindol was used to identify dopamine 
transporter binding, 1 nM [^H]SCH 23390 for dopamine D! receptor binding 
and 1 nM [^H] sulpiride for dopamine Dj receptor binding. Nonspecific binding 
was defined by the addition of 15 ^M nomifensine, 5 [iM flupenthixol and 10 
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i^M s(.)-sulpiride respectively, and the method for measuring specific binding 
values for the same as that described in section 2.2.1. 
2.3 Statistics 
Estimates of the equilibrium dissociation constant ( K � a n d the number of 
binding sites ( B ^ were determined using the non-linear computer curve fitting 
program LIGAND (Munson and Rodbard, 1980). Statistical differences were 
tested at each specific age between the control and cocaine-exposed groups 
using an unpaired Student's Mest. Significance was assumed at the level ofp< 
0.05. Results are expressed as mean 士 S.E.M 
2.4 Morphological Studies 
2.4.1 Tyrosine Hydroxylase (TH) Immunocytochemical Staining 
Tyrosine hydroxylase (TH) is the rate-limiting enzyme responsible for 
catecholamine biosynthesis. This enzyme is found in all neurons that produce 
the catecholamines dopamine, norepinephrine and epinephrine. These 
neurotramsmitters are among the best characterized for central nervous system 
actions. 
At PN 0，1, 2, 3，4，12 and 32 weeks, 1 � 2 male rats from each of the 
cocaine-exposed and control group were selected at random for 
immunocytochemical studies. Animals were perfused through the heart with 
saline solution (0.15 M NaCl) until the return blood was clear, this was 
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followed by a perfusion of 50�300 ml (depending on body weight) of fixative 
(4% paraformaldehyde and 4% sucrose in O.IM phosphate buffer, pH=7.2). 
Brains were immediately dissected out, postfixed for 2 hours in the same 
fixative, and placed overnight in 4% sucrose in O.IM phosphate buffer, 
pH=7.2. Whole brain coronal and sagittal serial sections were cut with a 
vibratome (Vibratome Series 1000) at 50 pm thickness. Free floating sections 
were mounted on gelatin coated slides [0.5% gelatin, 0.05% potassium 
chromium(III) sulfate] and dried for immunocytochemical staining. After two 
rinses in 0.0 IM phosphate buffer-saline (PBS), sections were incubated 
overnight in the TH antiserum (mouse monoclonal anti-TH, Science, 
Technology and Research, Cat. No. 22941, dilution 1:200) in PBS containing 
0.1% Triton X-100, 0.1% BSA and 0.05% NaN; (PBSTB) at room temperature. 
Sections were rinsed in PBS and placed in the biotinylated secondary antibody 
[Vectastain ABC Kit (mouse IgG)，PK-4002; dilution 1:200] in PBSTB for 2 
hours at RT. Sections were rinsed in PBS and arranged in the 
avidin-biotinylated enzyme (Vectastain ABC Kit, dilution 1:200) in PBS for 2 
hours at room temperature. Sections were washed in PBS and incubated for 10 
min in peroxidase substrate solution [0.05% diaminobenzidine 
tetrahydrochloride (DAB) in 0.05M Tris buffer, pH=7.2 with 0.02% hydrogen 
peroxide (H^O^)]. Hematoxlin (Sigma, H3136) was used for counter staining 
the nucleus. Sections were dehydrated in an alcohol series, cleared with xylene 
and mounted with mountant (Permount SP15-500, Fisher Scientific, lot no. 
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924295-24). Sections were observed under a photomicroscope (Nikon HFX-II) 
and approximately 70 serial sections per age group in each of the control and 
cocaine-exposed offspring were analysed. 
2.5 Molecular Genetic Studies 
The cDNA of cloned rat dopamine transporter (subcloned into PCR 2000 
vector, Invitrogen, USA), dopamine D: receptor (subcloned into pcDNA I 
vector, Invitrogen, USA) and 6-actin (sulcloned into pRM-1，Invitrogen, USA) 
for these experiments were obtained from Dr. KWK Tsim (Department of 
Biology, The Hong Kong University of Science and Technology). 
2.5.1 Material for DNA Insert 
2.5.1.1 Dopamine Transporter, D^ Receptor and B-actin 
cDNA Probe 
The rat dopamine transporter probe was a 496 bp fragment 
corresponding to transmembrane domains III to V of the rat dopamine 
transporter gene (Kilty et al.，1991, Shimada et al, 1991) that had been 
subcloned into the EcoR I site of PCR 2000 vector. The rat D^ probe was 2,5 
Kb fragment subcloned into the Pst I site of pcDNA I. The rat B-actin probe is a 
1.2 Kb fragment subcloned into the Pvu II site of pRBA-1. 
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2.5.2 Preparation for DNA Insert 
2.5.2.1 Competent Cells and Transformation of Plasmid 
A single colony of Escherichia coli JM109 strain (for dopamine 
transporter DNA), MCI061 (for dopamine D^ receptor DNA) and JM109 (for 
6-actin DNA) were grown in a sterile culture tube with 5 ml Luria-Bertaini 
(LB) medium (1% bacto-tryptone, 0.5% bacto-yeast and 1% NaCl, pH 7.4) 
with selected antibiotic and shaken overnight at 200 rpm on a shaker (Lab-line 
incubator shaker) at 37°C. About 0.6 ml of the bacterial culture was inoculated 
into 100 ml LB medium and the cells further grown at 37°C until the 
absorbance at 600 nm wavelength was in the range of 0.5 � 0 . 6 . The bacterial 
culture was centrifuged at 2000 x g (MSE，Mistral 2000 centrifuge), 4 � C for 10 
min. The pellet was resuspended in 20 ml ice-cold solutions of 50 mM at CaCl! 
(pH 8.0) and chilled on ice for 15 min. The suspension was then centrifuged 
again at 2000 x g, 4°C for 10 min. The pellet was further resuspended in 4 ml 
50 mM CaCl2. 0.1 ml of competent cells was used and the plasmid DNA was 
added. The mixture (plasmid and competent cells) were left to stand on ice for 
30 min and then heated at 42�C for 3 min. The mixture was then chilled on ice 
for 3 min, seeded onto LB plates with ampicillin (100 \ig/ml) and inoculated at 
3 7 � C overnight. 
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2.5.2.2 Growth Transformed Bacteria and Isolation of DNA 
2 colonies of the transformed JM109 (for dopamine transporter 
and B-actin DNA), MC 1061 cells (for dopamine D^ receptor DNA) carrying 
the plasmid with the DNA insert of interest were randomly selected and 
cultured in 3 ml LB medium with selected antibiotic at 37�C with shaking at 
200 rpm. After 6 hours, 3 ml culture was transferred to 500 ml LB medium 
under the same conditions for culturing overnight. The culture was then 
centrifuged at 4000 rpm (Sorvall RC 5C centrifuge), 4 � C for 15 min, and the 
pellet resuspended in 18 ml glucose buffer (50 mM glucose, 10 mM EDTA and 
25 mM Tris, pH 8.0). The cells were lysed with 2 ml of fresh lysozme solution 
(10 mg/ml in 10 mM Tris buffer, pH 8.0) and the DNA was released by 
incubating with 40 ml 0.2N NaOH and 1% SDS at room temperature (RT) for 
10 min. DNA was precipitated in a solution of ice-cold 5 M potassium acetate 
and centrifuged at 4000 rpm, 4°C for 15 min. 50 ml isopropanol was added into 
the supernatant and mixed for at least 10 min at RT. The solution was 
subsequently centrifuged at 5000 x g at RT for 15 min. The supernatant was 
discarded and the pellet containing the plasmid DNA was washed with 70% 
alcohol two times and resuspended in 3 ml Tris-EDTA buffer (TE buffer, 10 
mM Tris-Cl, 1 mM EDTA, pH 8.0). The DNA in the solution was further 
purified by CsCl centrifugation with 0.08% ethidium bromide in ultracentrifuge 
for 60K rpm (Sorvall, Dupont) at 20°C for 16 hrs. 
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2.5.2.3 Purification of cDNA by Genedean® II Kit: 
After 1 % agarose gel electrophoresis (Sambrook et al , 1989), the 
gel containing DNA of correct size was cut and subjected to DNA purification 
by using Genedean® II Kit (Bio 101 Inc., USA). The cut gel was placed in a 
1.5 ml microcentrifuge tube and dissolved in 3 volumes of Nal. The tubes were 
heated to 5 5 � C for 5 min. DNA was allowed to bind onto the 8 glassmilk 
(from Genedean® II Kit) for 15 min at RT. The pellet was washed three times 
with 0.5 ml ice cold NEW washing buffer (from Genedean® II Kit) and the 
pellet was resuspended in 20 i^l TE buffer. The mixture was incubated at 55°C 
for 5 min, centrifuged at 12000 x g for 10 sec and the supernatant was 
collected. The purified DNA insert was stored at -20°C and will be used for the 
Northern blot analysis. 
2.5.3 Isolation of Total mRNA From Tissue 
A total of 588 pups for the two treatment groups were used for the 
molecular genetic studies. Striatum, where D^ receptor mRNA are concentrated 
(Weiner et al , 1991) and midbrain, where dopamine transporter mRNA are 
located (Kilty et al , 1991) from control and prenatal cocaine-exposed rats were 
isolated at postnatal (PN) weeks 0 (n=50), 1 (n=35), 2 (n=18), 3 (n=16), 4 
(n=12), 12 (n=8), 32 (n=8). Tissues from each brain region and time point were 
pooled in liquid nitrogen and storage at -70�C. Lysis buffer, protein and RNase 
degradent, Oligo(dT) cellulose tablet, lysate, 5M NaCl, binding buffer, low salt 
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wash buffer and elution buffer used in the mRNA isolated procedures were 
from Invitrogen FastTrack mRNA isolation kit (cat. no. K1593-02). For the 
isolation of total mRNA, approximately 1 g tissue was weighed and grounded 
in pestle and mortar with liquid nitrogen and was then transferred to a 50 ml 
conical tube (Falcon 2070，USA). 15 ml lysis buffer with 0.3 ml protein and 
RNase degradent were added to the brain tissue contained in the 50 ml conical 
tube and homogenized with a Polytron homogenizer (scale at 20, 20 sec). The 
tissue mixture was shaken at 42 rpm at 45�C for 1 hour. The tissue mRNA was 
absorbed by 1 tablet of Oligo(dT) cellulose in 15 ml lysate with 0.9 ml 5M 
NaCl for 1 hour at room temperture. The remaining DNA, dissolved 
membranes, proteins and cell debris were washed off 3 times with 10 ml 
binding buffer (high salt buffer). The non-polyadenylate RNAs are washed off 
5 times with 0.8 ml low salt wash buffer. The mRNA was eluted twice with 
200 Elution Buffer and precipitated in absolute ethanol at -70°C overnight. 
The precipitated mRNA was centrifuged and air dried for Northern blot 
analysis. 
2.5.4 Northern Blot Analysis 
Isolated tissue was denatured using 17.5% formaldehyde and was 
electrophoresed in a 1% agarose gel according to Sambrook et al, (1989). 3 pg 
of poly (A)+ total mRNA was used for dopamine transporter (tissue from 
midbrain) and D: receptor (tissue from striatum) hybridization. After 
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electrophoresis, RNA markers containing molecular weight 9488-363 bp (8 
bands) were cut from gels and stained with ethidium bromide [1 of a 1 
mg/ml solution in diethyl pyrocarbonate (DEPC, Fluka) treated water] for 
verification of transcript size. Then the mRNA of interest was transferred from 
the gel by capillary action onto BA-S nitrocellulose (Schleicher and Schvell) 
and fixed by UV irradiation (Stratagene, UVstratalinker 1800). The 
nitrocellulose in membranes were prehybridized for 4 hrs at RT in 50% 
formamide, 4 x SSC (1 x SSC is 0.15M NaCl/0.015M trisodium citrate, pH -
7.0), 0.1% BSA Fraction V，0.1% Ficoll 400，0.5% SDS and 0.1 mg/ml 
denatured salmon sperm DNA. Labelled cDNA probes (10^ cpm/^g) for either 
D2 receptor or dopamine transporter were added to the above hybridization 
solution (106 cpm/ml), and hybridized overnight at 42°C. After hybridization, 
blots were rinsed three times in 2 x SSC and 0.1% SDS at RT for 30 min, then 
followed by two 30 min washes in 0.1 x SSC and 0.1% SDS at 60�C，and then 
a final 30 min wash 3 times in 0.1 x SSC at RT. Hybridized blots were placed 
on a X-ray film (Cronex 4，Dupont, USA) and exposed at -70°C for 24 � 4 8 
hours with an intensifying screen. The D! receptor or dopamine transporter 
probe was subsequently washed away using hot water, and was re-probed with 
a cDNA probe for B-actin using the same hybridization and washing conditions. 
The 6-actin probe was used as a control for the D: receptor and dopamine 
transporter. 
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2.5.4.1 Analysis of Northern Blots 
The mRNA bands were quantitated using a densitometer 
(Molecular Dynamics). The following equation was used to calculate the 
density ratio of mRNA for the control and cocaine-exposed group: 
determined RNA 
B-actin RNA 
The % difference in density ratio between the control and cocaine is 
measured as : 
control - cocaine | / control x 100% 
2.5.5 In Situ Hybridization 
2.5.5.1 Tissue Preparation 
4 whole brains from the control and cocaine-exposed female 
offspring were removed at PN 3 and 4 weeks by quick decapitation, and tissues 
were frozen in isopropanol on liquid nitrogen and kept in -70°C until ready to 
be used. The brains were cut in serial sections at 10 ^m in a cryostat (Cryocut 
1800, Reichert-Jung), thaw-mounted onto poly-L-lysine coated slides, and 
stored in -70°C until used for in situ hybridization. 
2.5.5.2 Preparation of Dopamine Transporter Ribroprobe 
A transmembrane domaines III to V of the rat dopamine 
transporter fragment (496 bp in length) was cloned into the EcoR I site of PGR 
2000 vector and used for synthesis of radioactively labelled complementary 
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RNA with 35S-UTP by T7 (antisense probe) and SP6 (sense probe) transcription 
system to specific activities of 1-2 x lO^cpm/^ig. The full length transcripts 
were alkali hydrolysed to generate probe with a mean length of 100 bp for 
efficient hybridization. 
2.5.5.3 In Situ Hybridization Histochemistry 
The prehybridization and hybridization was performed using a 
modified protocol of Chung et al. (1991). The sections were fixed in 4% 
paraformaldehyde in 0. IM PBS (pH 7.4) for 6 min and quickly washed 2 times 
with PBS and placed in 0.25% acetic anhydride in O.IM triethanolamine (pH 
8.0) for 10 min. The sections were dehydrated in 50%, 75%, 95% and 100% 
ethanol series and dried in a vacuum box. The sections were prehybridized in 
1:1 formamide and prehybridization buffer, [0.6M NaCl, 10 mM Tris (pH 7.6), 
0.01% BSA, 1 mM EDTA，0.02% Ficoll 400, 0.02% polyvinyl pyrrolidone, 
0.05% yeast RNA (type III), 0.005% yeast tRNA, 0.05% salmon testes DNA 
and 65 mM dithiotheritol] for 2 hours by placing slides on top of moistened 
filter paper in a Nalgene box at RT. The labelled probe (antisense or sense) was 
diluted (5 X 104 cpm/^1) with a mixture of formamide and hybridization buffer 
(50:50) and denatured for 10 min at 100°C before applying onto the sections 
after draining off the prehybridization buffer. Each section was incubated with 
2 X 106 cpm of radiolabelled probe overnight (16 hours) at 50�C. After 
hybridization, the sections were rinsed with a mixture of 50:50 formamide and 
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2 X SSC with 20 nM DTT for 30 min at 65�C，10 mM NTE (NaCl-Tris-EDTA) 
buffer rinse at 37�C for 3 x 10 min. Non-specific label was removed from the 
tissue by 30 min incubation in 20 \ig/ml RNase buffer (Sigma, in 10 mM NTE) 
at 37°C for two times. The sections were rinsed again with the 50:50 of 2 x 
SSC and formamide with 20 mM DTT and then rinsed in the following 
solutions : 2 X SSC (10 min, RT), 0.5 x SSC (10 min, 45�C) and 0.1 x SSC (3 x 
10 min, 45°C). The sections were prepared for autoradiography by graded 
series of alcohol with 0.3 M ammonium acetate and vacuum dried for 1 hour 
before emulsion (Kodak, NTB-2 emulsion) autoradiography as described 
previously (Chung et al., 1991). After 7 days incubation with the probe, 
sections were developed by placing them in Kodak developer D19 (2 min, 
15°C), water (1 min, 15�C)，Kodak fixer (4 min, 15�) and water (10 min, 
15°C). The sections were further rinsed 1 hour in water at RT before 
counter-staining with 0.1% cresyl violet for background observation. Sections 
were viewed under a Zeiss (Axiophot) microscope as described in Chung et al. 
(1991) and 8 sections each of PN 3 and 4 weeks from control and 
cocaine-exposed offspring were analysed. 
52 
CHAPTER III: RESULTS 
3.1 Litter Size, Birth Weight and Maternal Weight Gain 
It was shown on Table 1 that there was no significant difference between the 
control and cocaine-exposed group in the mean litter size, the mean birth 
weight of the offspring and the mean maternal weight gain during gestational 
day 7 to 21. There was also no difference in the number of stillbirths and 
deformaties observed between the two groups (observation not shown). 
3.2 Biochemical Studies 
3.2.1 Specific Binding 
Table 2 showed the specific binding (expressed as % of total bound) of 
dopamine transporter (DAT), dopamine D! and D^ receptors at PN 0，1, 2, 3，4, 
8, 12 and 32 weeks. The specific binding of [^H]mazindol-labelled dopamine 
transporter in the control group at PN 0 week was 52.3%, there was an 
age-dependent increase to a maximum of 87.4% by PN 8 weeks. Since the 
striatum contains mainly dopaminergic terminals, it was therefore asssumed 
that the high specific binding value measured is due to the binding to the 
dopamine transporters. The cocaine-exposed group showed comparable 
specific binding values to the control group with a specific binding value of 




Effects of cocaine exposure on litter size, mean birth weight (pups), maternal 
weight gain during gestation day 7-21. (Values 士 SEM) 
Control Cocaine-exposed 
Litter size 13.9 士 1.4 (n = 18) 13.5 士 1.1 (n= 19) 
Mean birth weight (g) 6.5 士 0.5 (n = 238) 6.7 士 0.4 (n = 256) 
Mean maternal weight gain 96.0 士 24.2 (n = 18) 92.9 士 14.5 (n = 19) 
during gestation day7-21(g) 
Table 2: 
The specific binding of 阳]mazindol-labelled dopamine transporter (DAT), 
[^H]SCH 23390-labelled dopamine D^ receptor and [^H]sulpiride-labelled 
dopamine D�receptor. The % of total bound is the mean of triplicate with each 
experiment repeated independently for three times in DAT and dopamine D � 
receptor; and two times in dopamine D^ receptor. 
% Bound 
Control Cocaine-exposed 
weeks DAT D, D � DAT D, D^  
0 52.3 35.6 58.4 54.6 44.1 62.6 
1 66.8 71.2 63.4 72.8 79.5 67.1 
2 75.5 88.8 74.4 79.4 90.5 75.7 
3 80.5 91.8 82.5 78.5 92.4 84.1 
4 82.1 93.1 86.2 80.6 92.8 85.5 
8 87.4 - - 83.4 - -
12 76.2 93.5 85.8 73.6 90.4 84.1 
32 75.9 90.5 86.0 77.4 91.4 85.4 
The specific binding of [^H]SCH 23390-labelled dopamine D^ receptor 
in the control group at PN 0 week was 35.6%, there was an age-dependent 
increase to a maximum of 93.5% by PN 12 weeks. The cocaine-exposed group 
showed comparable specific binding values to the control group with a specific 
binding value of 44.1% at PN 0 weeks reaching a maximum binding value of 
92.8% at also PN 4 weeks. The high specific binding value obtained by PN 12 
weeks was assumed to be attributable to the specificity of pH]SCH 23390 for 
Di receptors. 
The specific binding of [^H]sulpiride-labelled dopamine D�receptor in 
the control group at PN 0 week is 58.4%, there was also an age-dependent 
increase to 86.2% by PN 4 weeks. The cocaine-exposed group showed 
comparable specific binding values to the control group with a specific binding 
value of 62.6% at PN 0 reaching a maximum binding value of 85.5% at also 
PN 4 weeks. The high specific binding value obtained by PN 4 weeks was 
asssumed to be attributable to the specificity of [^H]sulpiride for D! receptors. 
3.2.2 Dopamine Transporter - Scatchard Analysis 
Table 3 showed the Scatchard analysis of [^H]mazindol-labelled 
dopamine transporters in the striatum from PN 0 to 32 weeks. In the control 
group, there was an eight-fold increase in the number of [^H]mazindol-labelled 
dopamine transporters (B„J from PN weeks 0-4 (0.21 土 0.22 to 1.71 土 0.04 
pmol/mg protein) with minimal change in number thereafter. In the 
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Table 3: 
[^H]mazindol binding (B腿 and K^) to striatal membrane in control and 
cocaine-exposed rat offspring. A significant decrease in B咖 was found in 
cocaine-treated offspring at PN weeks 3 and 4. Membranes were incubated 
with [^HJmazindol (1.56 _ 33 nM) with or without 15 ^M of nomifensine. 
N = 3，at each time point, measurement was in triplicate with each experiment 
repeated three times independently. * p < 0.05 significant difference from the 
control. 
Bmax (pmol/mg protein) Kd(nM) 
Control Cocaine- Control Cocaine-
Weeks exposed exposed 
0 0 . 2 1 士 0 . 2 2 0 . 1 4 士 0 . 0 6 1 6 . 8 4 士 6 . 1 0 1 1 . 8 0 士 4 . 4 6 
1 0 . 5 1 士 0 . 1 5 0 . 5 1 士 0 . 0 7 19.61 士 5.15 1 9 . 6 2 ± 2 . 0 4 
2 1.15 土 0 . 0 8 1.13 士 0.15 1 7 . 9 2 士 3 . 4 0 1 6 . 3 4 土 0 . 1 9 
3 1.53 土 0 . 1 2 0.93 士 0 . 1 6 * 1 4 . 9 9 士 1.53 1 4 . 7 3 土 1.17 
4 1.71 ± 0 . 0 4 1.35 士 0 . 0 8 * 1 3 . 7 8 士 0 . 1 4 1 2 . 0 4 士 0 . 5 0 
8 1.63 士 0 . 1 8 1.46 士 0 . 0 4 17.93 ± 4 . 6 2 1 6 . 3 1 ± 0 . 8 4 
1 2 1.70 土 0 . 2 8 1.60 士 0 . 2 8 14.16 土 2 . 5 1 1 4 . 6 2 土 2.35 
32 1.73 士 0.25 1.98 士 0.26 19.73 土 4.97 19.15 ±7.00 
cocaine-exposed group, at PN 3 weeks, there was a decrease of 39% (p < 0.05) 
in the number of dopamine transporters as compared to the control group. At 
PN 4 weeks, there was a 21% {p < 0.05) decrease in B in the 
� z ItlAX 
cocaine-exposed group when compared to that of the control. By PN week 8， 
there was only a 10% decrease (not statistically significant) in the number of 
dopamine transporters between the control and cocaine-exposed groups. At PN 
week 32, there appeared to be a reversal of trend (although not significant) with 
the cocaine-exposed group having a 12% higher number of binding sites as 
compared to that of the control. 
The binding affinity ranged from K^ = 16.84 土 6.10 to 19.73 士 4.97 nM 
for the control and 11.80 士 4.46 to 19.15 土 7.00 nM for the cocaine-exposed 
group from PN weeks 0-32. There was no significant difference observed in the 
binding affinity between the two groups at all the ages studied (Table 3). 
Fig. 1 showed one representative saturation curve and Scatchard plot of 
[^H]mazindol-labelled dopamine transporters in striatal membrane at PN 3 
weeks. The specific saturation binding in the control group was 
concentration-dependent and not reaching saturation level at 33 nM of 
[^H]mazindol (Fig. 1 A). The specific binding in the cocaine-exposed group was 
also concentration-dependent and reached saturation levels at 25 to 33 nM 
[屯]mazindol (Fig. 1 B). The Scatchard plot (Fig. IC) showed a 44% decrease 
in B and 16% in K, for the cocaine-exposed group when compared to the 
max ^ control. Values plotted are actual values, the line plotted is from the best fit 
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Fig. 1: 
A representative saturation curve and Scatchard plot of [^H]mazindol-labelled 
dopamine transporter (DAT) for the control and cocaine-exposed groups at PN 
3 weeks. (A) [^H]mazindol (1.56 - 33 nM) saturation curve showing the total, 
specific and non-specific binding as a function of free ligand in control and (B) 
cocaine-exposed group. (C) Scatchard plot of [^H]mazindol (1.56 - 33 nM) 
binding to DAT with estimates of B腿 and K^ values. The mean value of each 
concentration were obtained from triplicate measurement. There is a 44% 
decrease in B ^ and 16% in K^ for the cocaine-exposed group when compared 
to the control. The results are from one out of three individual experiments. 
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computer generated estimates and analyses from LIGAND showed no evidence 
for more than one binding site. 
Fig. 2 showed one representative saturation curve and Scatchard plot of 
[^H]mazindol-labelled dopamine transporters in striatal membrane at PN 32 
weeks. The specific binding in the control group was concentration-dependent 
and reached near saturation level at 33 nM of [^H]mazindol (Fig. 2A). The 
specific binding in the cocaine-exposed group was also 
concentration-dependent and reached near saturation level at 33 nM of 
[^H]mazindol (Fig. 2 B). The Scatchard plot (Fig. C) showed a reversal of 
trend with a 13% increase in B腿 value for the cocaine-exposed group when 
compared to the control. Values plotted are actual values, the line plotted is 
from the best fit computer generated estimates and analyses from LIGAND 
showed no evidence for more than one binding site. 
3.2.3 Dopamine Dj Receptor 
3.2.3.1 Association Curve 
Fig. 3 showed the association curve of 1 nM [^H]SCH 23390 
binding for dopamine D! receptors in the presence of 10 ^M flupenthixol in 
normal adult rat striatum. Tissues were incubated from 0 to 120 min. There is a 
time-dependent increase in ['H]SCH 23390 binding from 30 min incubation 
reaching 97.3% equilibrium at 120 min. 
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Fig. 2: 
A representative saturation curve and Scatchard plot of [3H]mazindol-labelled 
dopamine transporters (DAT) for the control and cocaine-exposed groups at PN 
32 weeks. (A) [^H]mazindol (1.56 - 33 nM) saturation curve showing the total, 
specific and non-specific binding as a founction of free ligand in control and 
(B) cocaine-exposed group. (C) Scatchard plot of [^H]mazindol (1.56 -33 nM) 
binding to DAT with estimates of B咖 and K^ values. The mean value of each 
concentration were obtained from triplicate measurement. There is a 13% B腿 
increase in DAT for the cocaine-exposed group when compared to the control. 
The results are from one out of three individual experiments. 
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Fig. 3: 
The association curve of 1 nM [^H]SCH 23390 binding for dopamine D^ 
receptors in the presence of 10 |iM flupenthixol. Tissues were incubated from 0 
to 120 min. There is a time-dependent increase in [^H]SCH 23390 binding from 
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3.2.3.2 Competitive Curve 
Fig. 4 showed the flupenthixol competition curve for the 
dopamine D! receptors using 1 nM [^H]SCH 23390 in normal adult rats striatal 
membrane at 2 hours incubation time (see 3.2.4.1). It was shown that a 
concentration of 10'^  M flupenthixol was sufficient to occupy 97.3% of sites 
recognised by InM [^H]SCH 23390. Values plotted are actual values in the 
presence of 1 nM [^H]SCH 23390. 
3.2.3.3 Scatchard Analysis 
Table 4 showed the Scatchard analysis of [^H]SCH 
23390-labelled dopamine D! receptor. In the control group, there was an 
age-dependent increase in the number of dopamine D^ receptor sites ( B ^ from 
PN 0 to 3 weeks (0.03 土 0.003 to 1.02 士 0.08 pmol/mg protein) followed by an 
age-dependent decrease from PN 4-32 weeks (0.79 士 0.051 to 0.53 士 0.109). 
The increase in B腿 was rapid during the first 3 weeks of development, having 
a 34 fold increase by PN 3 weeks when compared to PN 0 weeks. The decrease 
in B at PN 32 weeks was two fold that measured at PN 3 weeks (1.02 士 0.08 
mdx 
to 0.53 士 0.109 pmol/mg protein). In the cocaine-exposed group, at PN 12 
weeks there was a significant decrease of 25% and 44% ip < 0.001) in the 
number of dopamine D! receptor sites (B„J and in the binding affinity (K》， 
respectively. There was no significant difference at other age groups studied, 
however the cocaine-exposed group showed a slight trend of increase in B 腿 
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Fig. 4: 
Flupenthixol competition curve for the dopamine D! receptors using 1 nM 
[^H]SCH 23390 in normal adult rats striatal membrane at 2 hours incubation 
time. A concentration of 10'^  M flupenthixol was sufficient to occupy 97.2% of 
sites recognised by 1 nM [^H]SCH 23390. 
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Table 4: 
[^H]SCH 23390 binding (B舰 and K^ to striatal membrane in control and 
cocaine-exposed rat offspring. A significant decrease in B咖 and K^ were found 
in cocaine-exposed offspring at PN 12 weeks. Membranes were incubated with 
[^H]SCH 23390 (0.156 to 5 nM) with or without 5 ^M of flupentixol. N 二 2, at 
each time point, measurement was in triplicate with each experiment repeated 
two times independently. * p < 0.001 significant difference from the water 
control. 
B m a x (pmol/mg protein) K,(nM) 
Control Cocaine- Control Cocaine-
Weeks exposed exposed 
0 0 . 0 3 士 0 . 0 0 3 0 . 0 4 士 0 . 0 0 4 0.63 士 0 . 0 8 0.73 士 0 . 0 9 
1 0 . 1 5 士 0 . 0 1 6 0 . 2 0 士 0 . 0 0 5 0.73 士 0 . 0 2 0 . 7 8 士 0 . 1 4 
2 0 . 3 5 士 0 . 0 1 1 0 . 3 7 士 0 . 0 0 4 0 . 7 5 士 0 . 2 0 1.01 士 0 . 0 9 
3 1.02 士 0 . 0 8 0 1.13 士 0 . 1 9 7 1.48 士 0 . 0 4 1.44 ± 0 . 2 7 
4 0 . 7 9 士 0 . 0 5 1 0.65 士 0 . 0 1 9 1.49 士 0 . 2 9 1.24 ± 0 . 1 8 
1 2 0 . 6 1 士 0 . 0 0 4 0 . 4 6 士 0.005 * 0 . 7 0 士 0 . 0 2 0 . 3 9 ± 0 . 0 2 * 
32 0.53 士 0.109 0.48 士 0.073 0.56 士 0.17 0.63 士 0.22 
from PN 0-3 weeks followed by a trend of decrease in B ^ from PN 4-32 
weeks when compared to the control. The K^ values for the cocaine-exposed 
group also showed a similar trend of increase from PN 0-2 weeks (0.73 士 0.09 
to 1.01 土 0.09)，followed by a trend of a decrease from PN 3-32 weeks (1.44 士 
0.27 to 0.63 士 0.22) when compared to the control. 
Fig. 5 showed one representative saturation curve and Scatchard plot of 
[3H]SCH 23390-labelled dopamine D! receptors in striatal membrane at PN 2 
weeks. The specific binding in the control group was concentration-dependent 
reaching saturation level at 5 nM of [^H]SCH 23390 (Fig. 5A). The specific 
binding of the cocaine-exposed group was also concentration-dependent and 
reached saturation level also at 5 nM [^H] SCH 23390 (Fig. 5B). The Scatchard 
plot (Fig. 5C) showed only a 1% increase in B腿 for the cocaine-exposed 
group when compared to the control. Values plotted are actual values, the line 
plotted is from the best fit computer generated estimates and analyses from 
LIGAND showed no evidence for more than one binding site. 
Fig. 6 showed one representative saturation curve and Scatchard plot of 
[^H]SCH 23390-labelled dopamine D^ receptors in striatal membrane at PN 12 
weeks. The specific binding in the control group was concentration-dependent 
reaching saturation level at 5 nM of ['H]SCH 23390 (Fig. 6A). The specific 
binding of the cocaine-exposed group was also concentration-dependent and 
reached saturation level also at 5 nM [^H] SCH 23390 (Fig. 6B). The Scatchard 
plot (Fig. 6C) showed a 23.7% decrease in B腿 and 42% decrease in K.for the 
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Fig. 5: 
A representative saturation curve and Scatchard plot of [^H]SCH 
23390-labelled D^ receptors for the control and cocaine-exposed groups at PN 
2 weeks. (A) [^H]SCH 23390 (0.156 - 5 nM) saturation curve showing the total, 
specific and non-specific binding as a function of free ligand in control and (B) 
cocaine-exposed group. (C) Scatchard plot of [^H]SCH 23390 (0.156 - 5 nM) 
binding to dopamine Dj receptor with estimates of B腿 and K^ values. The 
mean value of each concentration were obtained from duplicate measurement. 
There is a only a 1% increase in B臓 for the cocaine-exposed group when 
compared to the control. The results are from one out of two individual 
experiments. 
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Fig. 6: 
A representative saturation curve and Scatchard plot of [^H]23390-labelled Dj 
receptors for the control and cocaine-exposed groups at PN12 weeks. (A) 
[3H]SCH 23390 (0.156 - 5 nM) saturation curve showing the total, specific and 
non-specific binding as a function of free ligand in control and (B) 
cocaine-exposed group. (C) Scatchard plot of [^H]SCH 23390 (0.156 - 5 nM) 
binding to dopamine D^ receptor with estimates of B腿 and K^ values. The 
mean value of each concentration were obtained from duplicate measurement. 
There is a 23.7% decrease in B腿 and 42% decrease in K^ for the 
cocaine-exposed group when compared to the control. The results are from one 
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cocaine-exposed group when compared to the control. Values plotted are actual 
values, the line plotted is from the best fit computer generated estimates and 
analyses from LIGAND showed no evidence for more than one binding site. 
3.2.4 Dopamine D^ Receptor 
3.2.4.1 Association Curve 
Fig. 7 showed the association curve of 1 nM 阳]sulpiride 
binding for dopamine D^ receptors in the presence of 25 ^M s(-)-sulpiride. 
Tissues were incubated for varying times from 0 to 4 hours. There was a 
time-dependent increase in [^H]sulpiride binding reaching 89.6% equilibrium at 
90 minutes incubation. 
3.2.4.2 Competitive Curve 
Fig. 8 showed the s(-)-sulpiride competition curve for the 
dopamine D! receptors using 1 nM [^H] sulpiride in normal adult rats striatal 
membrane at 90 minutes incubation time. It was shown that a concentration of 
10-5 M s(-)-sulpiride was sufficient to occupy 87% of dopamine D: receptor 
sites. Values plotted are actual values in the presence of 1 nM [^H]sulpiride. 
3.2.4.3 Scatchard Analysis 
Table 5 showed the Scatchard analysis of [^H]sulpiride-labelled 
dopamine D^ receptor. There is an age-dependent increase in the number of 
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Fig. 7: 
The association curve of 1 nM [^H]sulpiride binding for dopamine D�receptors 
in the presence of 25 i^M s(-)-sulpiride. Tissues were incubated at varying 
times from 0 to 4 hours. There was a time-dependent increase in [^H]sulpiride 
binding from 0 min reaching 89.6% equilibrium at 90 minutes. 
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S(-)-sulpiride competition curve for the dopamine D: receptors using 1 nM 
阳]sulpiride in normal adult rats striatal membrane at 90 minutes incubation 
time. A concentration of 10"^  M s(-)-sulpiride was sufficient to occupy 87% of 
the dopamine D? receptor sites. 
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Table 5: 
[^H]sulpiride binding (B腿 and K^ to striatal membrane in control and 
cocaine-exposed rat offspring. A significant decrease in B腿 was found in 
cocaine-exposed offspring at PN 0 weeks. Membranes were incubated with 
[^H]sulpiride (1.56 to 20 nM) with or without 10 i^M of s(-)-sulpiride. N = 3，at 
each time point, measurement was in triplicate with each experiment repeated 
three times independently. * p < 0.001 significant difference from the water 
control. 
Bmax (fmol/mg protein) K, (nM) 
Control Cocaine- Control Cocaine-
Weeks exposed exposed 
0 4 4 . 0 0 士 2 . 1 2 2 9 . 5 5 土 2.05 * 15.23 士 1.84 9 . 9 7 士 1.53 
1 3 5 . 7 0 土 5 . 0 9 3 4 . 0 3 士 0.81 6 . 2 9 士 0 . 2 8 5 . 8 2 土 0.61 
2 5 6 . 4 3 士 1.63 7 2 . 3 3 士 8.88 3 . 5 2 士 0 . 3 2 3 . 6 8 士 0.11 
3 9 8 . 0 0 士 2 2 . 6 3 1 0 5 . 5 0 士 1 9 . 0 9 3 . 7 7 士 0 . 7 0 3 . 3 6 士 0 . 0 8 
4 133.90 士 39.11 1 3 0 . 0 3 士 21.49 3.53 士 0.93 2.93 士 0 . 3 8 
12 144.13 士 42.20 124.78 士 10.53 4.24 士 1.07 4.49 士 1.51 
3 2 1 7 8 . 0 0 士 4 5 . 1 0 1 5 9 . 0 0 士 2 8 . 8 0 2 . 7 7 土 1.01 2.93 士 0 . 7 2 
4 
dopamine D�receptor sites (B„J from PN 0 to 32 weeks (44.00 士 2.12 to 
178.00 土 45.10 fmol/mg protein) in the control group. The increase in B ^ was 
rapid during the first 4 weeks of development, having a three fold increase at 
PN 4 weeks when compared to PN 0 weeks. This is followed by a slight 
increase till PN 32 weeks. In the cocaine-exposed group, there is a significant 
decrease {p < 0.001) in the number of dopamine D: receptor sites at PN 0 
weeks. However, there is no significant difference in the number of dopamine 
D2 receptor sites from PN 1 to 32 weeks between the control and the 
cocaine-exposed group although there is a trend of increase in the number of 
receptor sites at PN 2 weeks in the cocaine-exposed group. At PN 4，12 and 32 
weeks, there is a slight trend of decrease in the number of dopamine D � 
receptor sites in the cocaine-exposed group. 
The dissociation constant ( K � a t PN 0 is 15.23 士 1.84 nM, this is three 
times higher than that of PN 2 to 32 weeks. However, there is no significant 
difference in K^ values between the control and cocaine-exposed group from 
PN 0 to 32 weeks (Table 5). 
Fig. 9 showed a representative saturation curve and Scatchard plot of 
[^H]sulpiride-labelled dopamine D: receptors in striatal membrane at PN 0 
week. The specific binding in the control group was concentration-dependent, 
saturation was not reached even at 20 nM of [^H]sulpiride (Fig. 9A). The 
specific binding for the cocaine-exposed group also did not reach saturation at 
20 nM [3H]sulpiride (Fig. 9B). The Scatchard plot (Fig. 9C) showed a 32% 
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Fig. 9: 
A representative saturation curve and Scatchard plot [^H]sulpiride-labelled D^ 
receptors for the control and cocaine-exposed groups at PN 0 week.. (A) 
[^H]sulpiride (0.156 - 20 nM) saturation curve showing the total, specific and 
non-specific binding as a function of free ligand in control and (B) 
cocaine-exposed group. (C) Scatchard plot of [^H]sulpiride (0.156 - 20 nM) 
binding to dopamine D^ receptor with estimates of B腿 and K^ values. The 
mean value of each concentration were obtained from triplicate measurement. 
There is a 32% decrease in B腿 and 36% decrease in K^ for the 
cocaine-exposed group when compared to the control. The results are from one 
out of three individual experiments. 
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decrease in B顺 and 36% decrease in K^for the cocaine-exposed group when 
compared to the control. Values plotted are actual values, the line plotted is 
from the best fit computer generated estimates and analyses from LIGAND 
showed no evidence for more than one binding site. 
Fig. 10 showed a representative saturation curve and Scatchard plot of 
[^H]sulpiride-labelled dopamine D�receptors in striatal membrane at PN 2 
week. The specific binding in the control group was concentration-dependent 
reaching near saturation level at 20 nM of [^H]sulpiride (Fig. lOA). The 
specific binding for the cocaine-exposed group was also 
concentration-dependent, however it did reach near saturation level at 20 nM of 
[^H]sulpiride (Fig. lOB). The Scatchard plot (Fig. IOC) showed a 34% increase 
(not significant) in B咖 for the cocaine-exposed group compared to the control. 
Values plotted are actual values, the line plotted is from the best fit computer 
generated estimates and analyses from LIGAND showed no evidence for more 
than one binding site. 
3.2.5 Residual Cocaine Assay in Maternal Brain 
3.2.5.1 Specific Binding 
3.2.5.1.1 Dopamine Transporter 
Fig. 11 showed the specific binding of 5 nM 
[^H]mazindol-labelled dopamine transporters in the presence of 15 ^M 
nomifensine. Maternal striatal tissues were obtained at 0，3, 7 and 14 day after 
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Fig. 10: 
A representative saturation curve and Scatchard plot of [^H]sulpiride-labelled 
D2 receptors for the control and cocaine-exposed groups at PN 2 weeks.. (A) 
[^H]sulpiride (0.156 - 20 tiM) saturation curve showing the total, specific and 
non-specific binding as a function of free ligand in control and (B) 
cocaine-exposed group. (C) Scatchard plot of [^H]sulpiride (0.156 - 20 nM) 
binding to dopamine D: receptor with estimates of B腿 and K^ values. The 
mean value of each concentration were obtained from triplicate measurement. 
There is a 34% increase in B腿 for the cocaine-exposed group when compared 
to the control. The results are from one out of three individual experiments. 
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Fig. 11: 
The specific binding of 5 nM [^H]mazindol-labelled dopamine transporters in 
the presence of 15 |liM nomifensine. Maternal striatal tissues were obtained at 
0, 3, 7 and 14 days after delivery. A significant decrease (* p < 0.001) in 
specific binding was found in day 0 in the cocaine-treated maternal striatial 





















































delivery. A significant decrease of 83% (p < 0.001) in specific binding at AD 
day 0 was found in the cocaine-treated maternal brain when compared to that 
of the control. 
3.2.5.1.2 Dopamine Dj Receptor 
Fig. 12 showed the specific binding of 1 nM [^H]SCH 
23390 for dopamine D^ receptors in the presence of 5 i^M flupenthixol. 
Maternal striatal tissues were from 0, 3, 7 and 14 day after delivery. A 
significant decrease of 96.6% (p < 0.001) in specific binding at AD day 0 was 
found in the cocaine-treated maternal brain when compared to the control. 
3.2.5.1.3 Dopamine D: Receptor 
Fig. 13 showed the specific binding of 1 nM [^H]sulpiride 
for dopamine D�receptors in the presence of 10 i^M s(-)-sulpiride. Maternal 
striatal tissues were 0, 3, 7 and 14 day after delivery. A significant decrease of 
970/0 (p < 0.001) in specific binding at AD day 0 was found in the 
cocaine-treated maternal brain when compared to the control. 
3.3 Morphological Studies 
3.3.1 Tyrosine Hydroxylase (TH) Immunocytochemical Staining 
Examination of immunocytochemically stained whole brain consecutive 
sagittal sections (Fig. 14A) showed that there is TH-positive fibres and neurons 
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Fig. 12: 
The specific binding of 1 nM [^H]SCH 23390-labelled dopamine D! receptor in 
the presence of 5 jxM flupenthixol. Maternal striatal tissues were obtained at 0, 
3, 7 and 14 days after delivery. A significant decrease (*/? < 0.001) in specific 
binding was found in day 0 in the cocaine-treated maternal striatial tissue. The 
mean value for each time point were measured in duplicate. (Values 士 SEM) 
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Fig. 13: 
The specific binding of 1 nM [^H]sulpiride-labelled dopamine D�receptor in 
the presence of 10 |liM sulpiride. Maternal striatal tissues were obtained at 0，3, 
7 and 14 days after delivery. A significant decrease (* p < 0.001) in specific 
binding was found in day 0 in the cocaine-treated maternal striatial tissue. The 





































































Immunocytochemical staining for tyrosine hydroxylase (TH) in a 50 ^M 
vibratome sagittal section of the PN 12 weeks old rat offspring. (A) TH positive 
staining was found in the substantia nigra (SN), ventral tegmental area (VTA)， 
caudate putamen (CP)，internal capsule (IQ, olfactory tubercle (OT) and 
hippocampus (HP) in the whole normal rat brain sagittal sections (8 x 
magnification. Bar 二 1.25 mm). (B) TH positive stained caudate putamen and 
internal capsule in control (400 x magnification. Bar = 25 ^m) and (C) 
cocaine-exposed groups (400 x magnification, Bar = 25 ^m). At PN 12 weeks, 
an increase in TH-postive staining in the cocaine-exposed group when 
compared to the control. 
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in substantia nigra (SN), ventral tegmental area (VTA), caudate putamen (CP), 
internal capsule (IC), olfactory tubercle (OT) and hippocampus (HP). The 
examination of age groups at PN 0-32 weeks showed that there was an increase 
in TH-positive fibers in the CP and IC at PN 12 weeks only for the 
cocaine-exposed group (Fig. 14C) when compared to the control (Fig. 14B). 
There were no significant qualitative changes observed at the SN and VTA, 
where the dopaminergic cell bodies were concentrated, and in other 
TH-positive areas at all other age groups studied (data not shown). 
3.4 Molecular genetic Studies 
3.4.1 Northern Blot Analysis 
3.4.1.1 Dopamine Transporter 
Figure 15 showed an autoradiograph of the control group 
Northern blot analysis of the dopamine transporter cDNA probe. The results 
showed an age-dependent increase in the levels of dopamine transporter mRNA 
from PN 0-4 weeks (Fig 15)，with a 2.8 fold increase in density levels at PN 4 
weeks when compared to PN 0 weeks. The cocaine-exposed group showed an 
approximately 25%, 17% and 13% increase in density ratios at PN 0, 1 and 12 
weeks respectively, when compared to that of the control group (Fig. 16). 
However, at PN 4 weeks, the cocaine-exposed group showed a 20% decrease in 




A autoradiograph from Northern blots of the dopamine transporter (DAT) 
cDNA probe following hybridization with mRNA from isolated striatal tissue. 
(-)represents blots from the control group and (+) represents blots from the 
cocaine-exposed group. DAT cDNA probe is � 3 . 7 kb and JJ-actin cDNA probe 
is � 2 . 5 kb. There is an age-dependent increase in the levels of DAT mRNA 
labelling from PN 0 to PN 4 weeks in the control group. 
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Fig. 16: 
Relative level of DAT/B-actin mRNA were compared between the control and 
cocaine-exposed groups.The density of Northern blot of dopamine transporter 
showed an age-dependent increase in the density ratio from PN 0 to PN 4 
weeks in the control group. There is approximately 25%, 17% and 13% 
increase at PN 0，1 and 12 week in the cocaine exposed group when compared 
to the control. There is a 20% decrease in labelling density at PN 4 week in the 
cocaine-exposed group when compared to the control. Values are means of 






































































3.4.1.2 Dopamine D^  Receptor 
Figure 17 showed an autoradiograph of the control group 
Northern blot analysis of dopamine D: receptor cDNA probe. The results 
showed an age-dependent increase in the levels of D^ mRNA labelling from PN 
0-32 weeks (Fig. 17) with a 1.8 fold increase in density levels at PN 32 weeks 
when compared to PN 0 weeks (Fig. 18). The cocaine-exposed group showed 
an approximately 10% increase in density ratios at PN 3，4 and 12 weeks when 
compared to that of the control group (Fig. 18). 
3.4.2 In Situ Hybridization 
The bright- and dark-field autoradiographs showed that following 
hybridization with DAT antisense RNA probe at PN 3 and 4 weeks, dopamine 
transporter mRNA can be observed to be localized in the substantia nigra (SN) 
(Fig. 19) and ventral tegmental area (VTA) (Fig. 20) in both the control (Figs. 
19A, 20A) and cocaine-exposed offspring (Figs. 19B, 20B). The control 
section labelled with the DAT sense RNA probe showed a low level of 
background hybridization suggesting there is a high specificity for the antisense 
mRNA probe (Figs.l9C，20C). The significant difference between the control 
and cocaine-exposed groups were not quantitated due to the limited number of 




A representative autoradiograph from Northern blot of dopamine D: receptor 
cDNA probes following hybridization with itiRNA from isolated striatal tissue. 
(-)represents blot from the control group and (+) represents blots from the 
cocaine-exposed group. D^ receptor cDNA probe is � 2 . 9 kb and 6-actin cDNA 
probe is � 2 . 5 kb. There is an age-dependent increase in the level of D: receptor 
mRNA labelling in both groups. 
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Fig. 18: 
Relative levels of Dz/fi-actin mRNA were compared between the control and 
cocaine-exposed groups. There is an age-dependent increase in the density ratio 
in both groups with the cocaine-exposed group showing a 10% decrease in 
density ratio at PN 3，4 and 12 weeks when compared to the control. Values are 


















































































Bright-field autoradiographs of in situ hybridization distribution of dopamine 
transporter mRNA using ^^S-labelled antisense RNA probe in the substantia 
nigra of PN 3 weeks rats (400 x magnification), (A) dopamine transporter 
mRNA was shown to be present in numerous cells within the substantia nigra 
in the control and (B) cocaine-exposed group. (C) The control section labelled 
with sense RNA probe showed a low level of background hybridization. Bar = 
25 ^m 
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Fig. 20: 
Dark-field autoradiographs of in situ hybridization distribution of dopamine 
transporter mRNA using ^^S-labelled antisense RNA probe in the ventral 
tegmental area of PN 4 weeks rats (200 x magnification). (A) dopamine 
transporter mRNA was shown to be present in numerous cells within the vental 
tegmental area in the control and (B) cocaine-exposed group. (C) The control 
section labelled with sense RNA probe showed a low level of background 
hybridization. Bar 二 50 \im 
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CHAPTER IV ： DISCUSSION AND CONCLUSION 
4.1 Discussion 
The exposure of maternal cocaine at 60 mg/kg/day did not seem to affect the 
litter size, offspring birth weight and maternal weight gain during gestational 
days 7 to 21. This is in agreement with results from other studies which also 
showed no change in litter size and maternal weight gain when pregnant rats 
were exposed to cocaine ranging from 10-90 mg/kg/day. (Church et al.，1988; 
Spear et a l , 1989a; Church et al.，1990a; Johns et al, 1992a，b). Therefore, 
changes reported here are unlikely to be due to nutritional factors. 
The high specific binding (expressed as % total bound) reached by PN 4 
weeks for the dopamine transporters (DAT), Dj and D: receptors (Table 2) 
suggested that [^H]mazindol, [^H]SCH 23390 and [^H]sulpiride are ligands that 
are specific to the DAT, Dj and D: receptors respectively. Results from other 
studies also showed that these ligands bind with high affinity and are therefore 
highly specific for labelling these sites on the striatal synaptosomal membrane 
(Freedman et al., 1981; Billard et al., 1984; Javitch et al, 1984; Hess et al., 
1986; Ritz et al., 1987; Levant et al.，1993). The specific binding of dopamine 
transporter, dopamine D! and D^ receptors reached a maximum at PN 4 weeks 
indicating that they reached maturity by PN 4 weeks. The last 8 days of 
gestation in the rat are a period in which the dopaminergic neurons show the 
most rapid differentiation (Coyle and Henry, 1973). During the last week the 
formation of terminals begins, and while neuronal cell division is continuing in 
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the projection areas, the dopaminergic cell bodies are in the early stages of 
differentiation, dopamine is synthesized and begins to accumulate 2 full days 
before cellular differentiation is completed in the mesencephalon. The 
dopamine levels have reached only 30% of the adult value on postnatal day 1 
(Coyle and Henry, 1973). This low level of dopamine observed may suggest a 
low number of DAT, Dj and D: receptor sites present at birth, thus resulting in 
the low percentage of specific binding observed at PN 0 weeks (Table 2). 
Prenatal cocaine exposure from gestational day 7 to 21 exerts an effect 
on [^HJmazindol-labelled DAT in the rat striatum of the offspring. Scatchard 
analysis of striatal membrane in the control group showed that there was an 
age-dependent increase in DAT number from PN 0-4 weeks. This was also 
confirmed by Northern blot analysis showing a similar age-dependent increase 
till PN 4 weeks. This corresponded to the same period of time where D^ and D! 
receptor density reached adult levels (Deskin et al., 1981; Murrin, 1982; 
Nomura et al., 1982; Bruinink et al” 1983). It was shown that prenatal cocaine 
exposure resulted in a significant decrease in the number of dopamine 
transporter ( B ^ with no significant change in binding affinity ( K � a t PN 3 
and 4 weeks in the cocaine-exposed offspring. The significant decrease of B ^ 
in the striatum peaked at PN 3 weeks, this difference declining with age leading 
to near control levels by PN 12 weeks. This is indicative of a positive though 
transient effect of cocaine. By PN 32 weeks, the number of DAT in the 
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cocaine-exposed group was 12% higher than the control which may be 
suggestive of an overcompensation response. 
The B腿 and K^ values obtained from the present study could not be 
compared to that of other recent studies on DAT changes of prenatal 
cocaine-exposed mice as Scatchard analysis were not performed for the 
estimation of B咖 and K^ values in these studies (Byrnes et al , 1993; Koff and 
Miller, 1994). It was however reported in these studies that a decrease in DAT 
binding (expressed in dpm/mg tissue) was observed at PN 6 weeks (Byrnes et 
al., 1993) and an increase in DAT binding (expressed in cpm/mg tissue) at PN 
3 and 6 months was shown (Koff and Miller, 1994)，also suggestive of the 
existence of a compensatory response from PN 12 weeks onwards. 
This transient effect reported in the present and the study by Byrnes et 
al., (1993) may account for behavioral changes observed in studies showing an 
increase in rest-activity cycles at PN 20-23 days (Zmitrovich et al., 1992) and 
the hyperactivity observed at PN 20-23 days (Dow-Edwards, 1989b; Hutchings 
et al., 1989) and at PN 30 days (Henderson and McMillen, 1990) in the 
cocaine-exposed rat offspring. This lack of long term effect may also explain 
the inconsistent neurochemical and neurobehavioral findings reported by other 
authors at different time points studied (see section 1.2.2.4; 1.2.2.5). 
The Northern blot analysis of dopamine transporter showed a 20% 
decrease in mRNA density at PN 4 weeks in the cocaine-exposed group, this 
corresponded to the same period where a 21% {p < 0.05) decrease in B咖 in the 
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cocaine-exposed group was observed. It is however unclear as to why a 
corresponding decrease in mRNA level was not detected at PN 3 weeks, 
although a recent in situ hybridization study on prenatal cocaine-exposed rat 
whole brain showed that there was no change in DAT mRNA level from PN 
0-3 weeks (de Bartolomeis et al., 1994). The present in situ hybridization study 
showed that there was no qualitative difference observed in DAT mRNA 
density at PN 3 and 4 weeks between control and cocaine-exposed groups. PN 
3 and 4 weeks was selected for DAT mRNA study in order to confirm the 
results of the significant decrease observed in the number of DAT in the 
cocaine-exposed group. Changes in DAT mRNA levels were not detected using 
in situ hybridization may be due to, firstly, a small number of serial sections 
examined for this study and, secondly, the mechanism and/or response that 
causes presynaptic change in DAT numbers may be different to that which 
occurs at the cell body, the site where change in gene expression occurs. 
Quantitation on a larger number of serial hybridized sections with an image 
analysis system will elucidate the discrepancies observed between the in situ 
hybridization study and the Northern blot analysis. 
From PN 12-32 weeks，the density ratio of DAT mRNA is slightly 
higher in the cocaine-exposed groups when compared to the control group 
supporting the suggestion of an overcompensation response observed in the 
Scatchard analysis. 
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Dopaminergic neurons are detected on gestation day 12-14 in the rat 
(Olson and Seiger，1972; Le Moal and Simon, 1991; Santana et al , 1992) and 
were also shown to undergo rapid differentiation during the last 8 days of 
gestation (Coyle and Henry, 1973) with subsequent increases in DA levels from 
gestation day 17，reaching adult levels at PN 60 days (Santana et al , 1992). 
Most of the synaptogenesis of rat dopaminergic neurons occurs postnatally and 
continues into adulthood (Le Moal and Simon, 1991). The changes in 
[^H]mazindol-labelled dopamine transporter at PN 3 and 4 weeks development 
and the changes in mRNA levels at PN 4 weeks associated with prenatal 
cocaine exposure suggested that the prenatal insult of dopaminergic neurons 
during development may result in a period of postnatal dysfunctional synaptic 
maturation affecting synaptic parameters like DAT. 
Results from the present study are also in agreement with other prenatal 
cocaine exposure studies showing morphological, physiological and 
biochemical changes at PN 3 and 4 weeks (Scalzo et al., 1990; Akbari and 
Azmitia, 1992; Salamy et al , 1992) suggesting that this may be a critical period 
in the maturation of synaptic profiles during which prenatal cocaine exposure 
may have an important effect. 
The increase in mRNA density levels at PN 0 and 1 week in the 
cocaine-exposed group suggested that prenatal cocaine exposure results in an 
earlier change in gene expression of DAT in the cell body than that found in 
the presynaptic transporter sites. This shows that the development of the 
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number of DAT in the presynaptic terminal may be independent from that of 
the mRNA levels in the cell body. This was shown in the present study where a 
difference of DAT mRNA levels and B^,, values were observed. This 
I l i a A 
independence in development was also shown to be present in D! receptors 
(Feigenbaum and Yanai，1984). The synthesis of dopamine, reaching adult 
levels at PN 60 days, and that of DAT, D! and D�receptors at PN 4 weeks (28 
days), further supports the concept of independence in development between 
the level of gene expression and transporter/receptor numbers. It should 
however be noted that change in mRNA levels at PN 0 week as a result of 
residual maternal cocaine (Fig. 11) cannot be ruled out. 
For the dopamine D^ receptor, results from the control group showed 
that there was a single binding site for [^H]SCH 23390 with a B ^ ranging from 
0.03 to 1.02 pmol/mg protein and a K^ from 0.63 to 1.48 nM at PN 0 to 3 
weeks (Table 4). The B腿 and K^ values reported in this study is in agreement 
with that shown by Scalzo et al. (1990)，that is，B^ value of 0.36 pmol/mg 
protein and K^ value of 1.22 nM. At PN 12 weeks in the cocaine-exposed 
group, it was shown that there is a significant decrease of 25% and 44% (p < 
0.001) in the number of dopamine D! receptor sites ( B ^ and in the binding 
affinity (K》，respectively (Fig 6; Table 4). Results from the present study is in 
partial agreement with that reported by Scalzo et al. (1990) where no alteration 
in Dj binding were observed in the nucleus accumbens or striatum at PN 3 
weeks. A recent in situ hybridization study also showed that there was no 
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change in mRNA levels of D^ receptor at PN 3 weeks (de Bartolomeis, 1994). 
The present study is contrary to that reported by Dow-Edwards et al. (1989a,b; 
1990) where an increase in D! receptor binding was observed at PN day 11 and 
20 and in the substantia nigra at PN day 60 in the cocaine-exposed offspring. 
However due to the lack of other longer term studies examining the change of 
Di receptors beyond PN 60 days (Dow-Edwards et al., 1990)，it was not 
possible to further compare the present decrease at PN 12 weeks with that of 
other studies. It was however observed from behavioral studies that the 
offspring exhibited abnormal behaviors when placed in novel environments at 
PN 60 and 180 days after prenatal cocaine exposure. The cocaine-exposed rats 
was shown refusing to enter an open field and took longer to find a submerged 
platform, suggestive of altered dopamine receptor function (McMillen et al, 
1990). Due to the unavailability of the D! receptor cDNA locally, the temporal 
change observed at PN 12 weeks was not verified by molecular genetics 
studies. 
Both Scatchard analysis and Northern blot analysis on the dopamine D: 
receptors showed an age-dependent increase in D�receptor number and mRNA 
synthesis during PN 0 to 32 weeks with the most rapid increase during the first 
4 weeks of development. This trend in the development of the D�receptor was 
similar to that observed by Nomura et al., (1982) using [^H]spiperone binding 
where a rapid increase in D�receptor sites, tripling and reaching a peak by PN 
4 weeks was also observed. 
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From the results, the control group showed a single binding site for 
pH]sulpiride with a B咖 ranging from 44 to 178 fmol/mg protein and a K^ 
ranging from 15.23 to 2.77 nM at PN 0 to 32 weeks. The B腿 and K^ (with the 
exception of PN 0 weeks) values reported in this study is in agreement with 
previous published data on adult rat striatum B腿 values of 240 fmol/mg 
protein (Freedman et al.，1981) and K^ values of 3.2 nM (Jastrow et al., 1984) 
respectively. Of all the age groups studied, only animals at PN 0 weeks showed 
a significant difference in B腿 value. The value for the specific binding of 
[^H]sulpiride at PN 0 week is only 58% (see Table 2), and that saturation was 
not reached at 20 nM [^H]sulpiride for both control and cocaine-exposed group 
(Figs. 9A, B). It is therefore concluded the B腿 and K^ values at PN 0 week 
may not be entirely reliable. Another factor for this difference between the 
control and cocaine-exposed group may be due to the masking of prenatal 
cocaine effects resulting from residual cocaine present in maternal milk as the 
pups were not fostered to untreated dams. It had been shown that cocaine 
concentrations were intensified in breast milk as evidenced by a milk : blood 
concentration ratio of about 8, higher than in corresponding maternal brain or 
liver (Wiggins et al., 1989). It was shown in the present study that there was a 
97% decrease in the [^H] sulpiride-labelled dopamine D? receptor binding in the 
maternal striatal tissue of the cocaine-exposed group after delivery (AD) day 0 
when compared to the control, confirming this possibility. There is also a 83% 
and 97% decrease in [^H]mazindol-labelled dopamine transporter and [^H]SCH 
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23390-labelled D^ receptor binding in the maternal striatal tissue further 
confirming the presence of residual maternal cocaine at the time of tissue 
sampling in the offspring at PN 0 weeks. However, due to the short half-life of 
cocaine (Wiggins, 1992), at AD 3 days, the residual cocaine could no longer be 
detected (Figs. 11, 12, 13). 
Scatchard analysis revealed no significant changes in the B腿 and K^ of 
the D2 receptor from PN 1 to 32 weeks although a trend of increase in B ^ at 
PN 2 and 3 weeks was observed (Fig. 10，Table 5). This is partially in 
agreement with that observed by Scalzo et al.，(1990) where an approximately 
17% increase in receptor binding was observed in the cocaine-exposed group 
when measured at PN 3 weeks. At PN 32 weeks, there seemed to be a reversal 
of trend where an approximately 10% decrease in B腿 was observed. This 
reversal of trend were also reported by Henderson et al. (1991) showing a 23% 
decrease in B腿 by PN 25-26 weeks after an initial slight increase (not 
significant) at PN 4 weeks in the cocaine-exposed group. 
The dopamine D�receptor Northern blot analysis showed a 10% 
increase in mRNA levels at PN 3, 4 and 12 weeks in the cocaine-exposed group 
also suggesting there may be some compensatory response. However, changes 
in the D�receptors were not in the same magnitude as that observed in the DAT 
where a 39% and 21% decrease in DAT number at PN 3 and 4 weeks 
respectively, and a 20% decrease in mRNA level at PN 4 weeks were shown. 
This suggested that despite the changes in the DAT, there were minimal 
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changes in the dopamine D^ receptor sensitivity in the striatum. This response 
of D2 receptor is different to that reported in nigrostriatal denervation studies 
where a 40% (Graham et al , 1990) and 100% (Joyce et al , 1986) increase in 
D2 receptors were observed accompanying a loss of over 90% of dopamine 
transporter. Similarly, an hypoxic-ischemic brain injury study showed that 
there was significant decreases in B腿 and K^ values for Dj receptors and in 
B舰 for D2 receptors in the lesioned caudate-putamen with no significant 
change in [^H]mazindol-labelled DAT (Przedborski et al., 1991). This 
suggested that postsynaptic changes in receptor sites and binding affinity may 
not bring about a concomitant change in presynaptic sensitivity or vice versa. 
Furthermore, the present study also showed that there is minimal change 
in D2 receptor which is also not comparable to that observed for D! receptor 
where a decrease in B腿 in the cocaine-exposed group at PN 12 weeks was 
observed. 
It is well known that D^ and D! receptors are the two major subtypes of 
dopamine receptors with different biochemical (Kebabian and Calne, 1979), 
pharmacological (Billard et al., 1984; Creese et al., 1983), anatomical (Creese 
et al., 1983), and behavioral profiles (Amt, 1985; Amalric et al., 1986; Barone 
et al., 1986). Regional differences in affinity states and the distributions and 
densities of the receptors and their subtypes were also observed (Richfield et 
al., 1989). Behavioral (Mailman et al., 1984; Amt, 1985; Amalric et al., 1986; 
Barone et al , 1986; Robertson and Robertson, 1986) and electrophysiological 
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(Walters et al , 1987) studies suggested that D^ receptor may play a 
"modulatory" or "synergistic" role in the functions of the D: receptor although 
the mechanism through which this interaction can occur remains uncertain. 
Although it is unclear whether the present minimal change in D: 
receptor is modulated by change in the D^ receptors, results so far indicated 
that prenatal cocaine exposure differentially affects the D^ and D: receptors as 
well the dopamine tianspoiters. 
Tyrosine hydroxylase (TH) is the rate-limiting enzyme of catecholamine 
biosynthesis. TH plays an important role in regulating DA and NA availability 
in the brain. In the present study, there was no qualitative difference observed 
in TH stained whole brain serial sections of the cocaine-exposed group at all 
age groups study except at PN 12 weeks. An increase in TH immunostaining 
was observed in the caudate putamen and internal capsule in the 
cocaine-exposed group at PN 12 weeks. This further supports the existence of a 
postnatal compensatory mechanism. 
This present result however is contrary to that shown by Akbari and 
Azmitia (1992) where an increase in TH immunostaining of catecholamine 
fibers in the hippocampus, anterior cingulate cortex, and parietal cortex at PN 
28 days cocaine-exposed rats was observed. Changes observed in these regions 
implied that cocaine may exert its effect not only on the nigrostriatal 
dopmainergic pathway, demonstrated by change at the caudate putamen shown 
in this study, but also in the mesocorticolimbic pathway. The 
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mesocorticolimbic pathway, involving areas like ventral tegmental area, 
nucleus accumbens, frontal and cingulate cortex, and olfactory tubercle, have 
been implicated in cocaine addiction and withdraw (Kuhar et al.，1991; Xia et 
al., 1992; Cerruti et al., 1994). This was supported by the report that in chronic 
cocaine treated adult rats, there was a 30-40% increase in immunoreactivity in 
the ventral tegmental area (component of mesolimbic dopamine system) with 
no change observed in the substantia nigra and striatum, implicating the 
mesocorticolimbic dopaminergic system in cocaine addiction in the adult 
(Beitner-Johnson and Nestler, 1991). However, in the present study no such 
changes involving the mesocorticolimbic system was observed in prenatal 
cocaine exposure. Furthermore, comparsion between the present study and that 
of Akbami and Azmitia (1992) cannot be made due to the authors' examination 
at a fixed time point of only PN 28 days. 
So far morphological and in situ hybridization results from the present 
study suggested that prenatal cocaine exposure exerts its effect only on the 
nigrostriatal dopaminergic system of the offspring. Preliminary receptor 
binding assays from frontal cortex, hippocampus, brainstem, hypothalamus and 
cerebellum also revealed no significant changes after prenatal cocaine exposure 
(data not shown). Furthermore, biochemical and Northern blot analysis from 
the present study suggested that major changes in the dopaminergic system 
involved that of the striatum, plus some changes in the substantia nigra, which 
is the main components of the nigrostriatal pathway. 
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4.2 Conclusion 
In conclusion, the present long-term study showed that there is an 
age-dependent increase in the number of dopamine transporters (DAT), D! and 
D2 receptor from PN 0-4 weeks during development. 
Prenatal cocaine exposure resulted in the transient decrease in the 
number of DAT at PN 3 and 4 weeks and in the transient decrease of mRNA 
levels at PN 4 weeks in the cocaine-exposed offspring. D^ receptor also showed 
a transient decrease in receptor number and binding affinity at PN 12 weeks in 
the cocaine-exposed offspring. Minimal changes in receptor number and 
binding affinity and in mRNA levels were observed in the D�receptors from 
PN 0-32 weeks. 
Morphological studies showed that there is an increase in TH 
immuno-labelled fibre density at PN 12 weeks in the cocaine-exposed offspring 
suggestive of a compensatory response. This was also evident in the slight trend 
of increase in DAT number at PN 32 weeks and the increase in mRNA levels at 
PN 0, 1 and 12 weeks. 
At present, evidence seemed to suggest that prenatal cocaine exposure 
primarily exerts a transient effect on the nigrostriatal dopaminergic system of 
the offspring. This may account for some of behavioral changes like increased 
locomotor activity, tremulousness and organizational responses reported in 
some human and animal studies (see section 1.2.1.3.6 and 1.2.2.4). The 
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transient effects observed in this study may also explain the positive or lack of 
response reported in some of the short term or fixed time point studies. 
The dopaminergic neurons with its receptors and transporters, help 
maintain the homeostasis of dopamine，a key neurotransmitter in the brain 
where integration and control of sensory and motor processes，learning and 
memory’ cognitive functions and reinforcement processes occurs (see Le Moal 
and Simon, 1991 for review). As a result of its key role in maintaining a 
homeostatic response, it is not surprising that these neurons may possess some 
mechanism for compensatory response when subjected to biochemical or 
mechanical insults. 
It had been shown that dopaminergic cells demonstrate enormous 
plasticity after dopaminergic lesion; normal dopaminergic function can still 
exist with only a < 10% dopaminergic transmission capacity remaining (Le 
Moal and Simon, 1991). Therefore it is not unreasonable to assume that a 
compensatory mechanism may exist after prenatal cocaine insult which enables 
the recovery of the number of dopamine transporter and receptors. 
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G I 監 認 品 『 P R E N A T A L COCAINE EXPOSURE ON THE DOPAMINE UPTAKE SITES AND D I RECEPTOR SITES OF 
and DJS3ng2. Dept of Anatomyl and Dept of Biochemistry2. Chinese University of Hong Kong. Shatin. NT.. Hong 
E p i d e m S i a dramatic Increase In the no. of Infants whose mothers have used cocaine during pregnancy. 
are Important .n the of the t T a S T d 
丨Ap?咖ayf.�3H�mazindol a dopamine uptake carrier, was used to megPsureg the cfLgerin u'ptake sites and 
【:5H】SCH 23390. a selective Di receptor antagonist, was used to measure the changes in dopamine Di receptor binding. 
fmol/ma'\mt?nHZ®n /n ^  mnnJc® s^atum Showed an age-dependent increase In the no. of l3H]mazlndol-labelled uptake sites (28^62 
S l ^ r P ^ • ) I 0 i。3 months. Cocaine exposed offspring showed a decrease (maximum of 30% at 3 weeks) in the no of uptake sites 
t C O j 产 to 3 months when compared to the control. The striatum also showed the highest no. of [3H]SCH 23390-^3^16^ D r 二 r 
二 = = 二 二 i n c r e a s e cjf 9 to 332 fmol/mg protein from 0 to 4 weeks. The cocainL exposed offspring also s h S a 
义 r ‘ = i r r Z n 二 h J h ？H 3 we，ks "" the no. of …receptor sites when compared to the control during the first 4 weeks of development J J f^ce beS e^tn Jh^  ^Tgroup? �caine exposed groups showed a decrease In the no. of Di receptor sites with no sign^ cant 
The present data suggested that the decrease in dopamine uptake and receptor binding in the cocaine-exposed offspring may result 
二 the extracellular increase of dopamine content, thus explaining the increase In locomotor activity observed. The decrease in Di receptor 
Dinclmg at 3 months may be reflective of a compensatory mechanism indicating a lack of permanent damage. 
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INTENSIVE UBIQUITIN-IMMUNOREACTIVE PRODUCTS DEPOSITED IN THE MOTONEURONS OF THE SPINAL CORD OF 
THE WOBBLER MOUSE. A MODEL FOR MOTONEURON DISEASE 
Y.P. Deng and L.L Vacca-Galloway. Department of Anatomy, University of Hong Kong, Hong Kong 
The Wobbler mouse posseses an autosomally-recessive inherited motoneuron disease that provides us with a model to study human 
motoneuron diseases (Infantile Spinal Muscular Atrophy and Amyotpophic Lateral Sclerosis). Pathologically, the anterior horn cells of the 
Wobbler mouse undergo perikaryal vacuolar degeneration which is pathognomonic for this disease. Most striking in the motoneuron depletion 
is the loss of motoneurons in the region of the spinal cord enlargements, especially at the cervical level. Our previous research has found that 
the diseased motoneurons in cervical ventral horn contain decreased amounts of intraneuronal acetylcholine esterase (Vacca-Galloway and 
Steinberger, 1986) and calcitonin gene-related peptide (Vacca-Galloway and Zhang, 1991 ), where as the numbers of neuronal processes 
containing substance P, serotonin, thyrotropin releasing hormone, leudne^enkephalin and other neuropeptides Increase around the 
degenerating motoneurons ( Vacca-Galloway and Steinberger. 1986; Vacca-Galloway and Zhang, 1991). The protein known as ubiquitin, 
recently identified as a marker for the degeneration of motoneurons in postmortem specimens of human motoneuron diseases, has not been 
studied in Wobbler. Ubiquitin is a 76-aminoacid protein involved in the ATP-dependent removal of abnormal cytoplasmic proteins. In human 
neural degenerative disorders (Amyotrophic Lateral Sclerosis, Parkinson's disease, Alzheimer's disease) and the Mnd mouse mutant with 
motoneuron disease, ubiquitin frequently appears within the diseased motoneurons In abnormal abundance ( Leigh et e!., 1991; 
Mazurkiewicz..l99l). Therefore, we applied immunocytochemistry to investigate whether ubiquitin is associated with motoneuron degoneration 
in the Wobbler mouse. Our results showed that the motoneurons of the cervical spinal cord from the Wobbler mouse have intensive ubiquitin-
like immunoreactive products where as only weak Immunoreactivity for ubiquitin was found in the normal phenolype control littermate 
specimens. It is suggested that the pathological mechanisms Involved in the degeneration in motoneurons of the Wobbbler mouse, as In the 
human, may be associated with abnormal amounts of ubiquitinated Inclusions. 
Acknowledgement: This work is supported by awards from UPCG(338/031/0006) and Croucher Foundation(360/031/0814),as well as 
CRGP(372/162/6396). 
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RRRQRP?^ T^〜LNOF«CMOAC^NE REDUCES THE DOPAMINE 溫滥 p 溫 f j 溫溫 S 严 T Y T E o R R G i ^ = N � T F 溫 二 ? 严 _ 旧 爾 V E N T R A L 
I.Marev-Semner*. M. rJmanf npd M 丨/vi- 丨|•丨川們•(• p, Cerrutl*. N. PilOtte*. G. UN* and M .1, Kllhflr*, 
INSERM U. 114, Coll6ge de France, 75005 PARIS FRANCE Labs. Mol. Pharmacol , and Mol. Neurobiol. ARC/NIDA Box 
‘ 5180, Baltimore, M.D., 21224. 
In order to explain the selective toxicity of 1-methyl-1 2 3 6-
tetrahydropyridine (MPTP) towards the nigro-striatal dopaminergic Cloning cDNAs encoding the rat dopamine transporter 
neuron…we hypothesized that a constitutive "weakness" of their (DAT1) allows assessment of the cocaine-induced chanaes of 
e ^ n工 ’ i a b o力 s m could account for their special sensitivity to the its expression in the rat brain. Oligonucleotides and a full-
ATP-depleung effects of this neurotoxin. As an index of the cncrgetic lenght cDNA complementary to DAT1 mRNA hybridize to a 3 7 
T Sjoiis^iJ, we measured the inhibitory effects of rotcnone (an inhibitor kb mRNA prepared from the rat midbrain that is absent in 
of the oxidative phosphorylation on the specific uptake of different cerebral cortex or cerebellum 二rTVeate i d a ^ fnr ? 
neurotransmu ers m mouse striatal synapiosomes and in mesencephalic weeks (1 mg/kg i v e v e ^ 12 min ove a 2h oerioH? xhk 
neurons from 14-day-old mouse embryos. In synaDtosomes exnosure to H t 二厂 ? 9 . • : ®； ‘ ) . 叫？ over a ^n period). This 
lO^M rotenone inhibited 2.2-fold more the fh二 schedule of administration mimics the total dose and pattern of 
those of serotonin and GABA which were equally affected In cultured ？caine intake in animals self-administering the drugs, 
neurons, the inhibitory effects of IpiM rotenone were 11 times more Cocaine treatment followed by 10 days withdrawal induced a 
important on dopamine uptake than on serotonin or GABA uptake. This decrease in [3H�WIN35,428 (a specific dopamine uptake 
higher sentitivity of the dopamine uptake to ATP depleiion was also inhibitor) binding by 23% in the nucleus accumbens but not in 
confirmed using three other unrelated metabolic inhibitors: aniimycin A the caudate-putamen in comparison with saline treatment In 
[O.lj^M), MPTP ( 1 0 0 _ and potassium cyanide ( 5 0 0 _ . situ hybridization using specific oligonucleotides reveals 
f ™ ™ ® ' ^ ' found that the synaptosomal uptake of dopamine was dense hybridization in neurons of the substantia nigra pars 
175-toId more inhibited by lO^iM rotenone in the dorso-latcral pari of compacta and lower densities in ventral tegmental area (VTA) 
the striatum than in the nucleus accumbens which contains the subdivisions. Ten days after coca ine treatment the tota dopaminergic nerve terminals of the MPTP-rcsistani ineso-limbic number of cells exprUs^nrDSfrTRNrrn eacf； 二 b : 
induced, for instance, by the mitochondrial a b 二 = 二 。f VTA (in erfasc.cular and caudal linear nuclei. 22% and 36% 
recently been described in Parkinson's disease respectively), after withdrawal of cocaine. These cells are 
known to belong to the mesocorticolimbic system which is 
involved in the cocaine reinforcing effect. 
C ^ D 
THE EFFECTS O F PRENATAL COCAINE EXPOSURE ON THE , VARIATIONS IN DOPAMINE D1 AND D2 RECEPTORS IN THE TERMINAL 
DOPAMINE UPTAKE S ITES IN THE OFFSPRING - A DEVELOPMENTAL FIELD REGIONS AS RELATED T O INDIVIDUAL DIFFERENCES. M. S. 
STUDY Hooks*, and P. W. Kalivas, Alcohol and Drug Abuse Program, Washington State 
A.StadlinV H.L.Choi'* and D.Tsanq''. Dept of Anatomy' and Biochemistry2, University, Pullman, WA 99164-6520, USA. 
Chinese University of Hong Kong, Shatin, NT.. Hong Kong , H i ^ responding rais (HR) to a novel environment show a greater 
vulnerability to drup of abuse such as arnnhclaminc and cocaine than low 
^ . , , 』 . , „ . .. L . responding rats (LR) to a novel environment. Rcccnl studies have also shown that 
Cocaine was shown to exert its psychotropic effects primarily by inhibition HR have a greater mcreasc in extracellular dopamine in the nuclcus accumbens 
Of the reuptake of dopamine, norepinephrine and serotonin, as well as (NACC) and caudate putamcn (CP) than LR {following amphetamine or cocainc 
exerting other neurochemical changes in the adult CNS. However, the challenges. In the current studies subjects were screened for locomotor response 
neurochemical effects of cocaine on the offspring from cocaine-abused Ij? novelty and then the NACC, CP and the medial frontal cortex (MFC) were 
mothers have scarcely been defined. Pregnant Sprague-Dawley rats were 广ssecied. Receptor binding s tujes using radbaciivc liaand binding m tiss^ 
administered orally with cocaine (60mg/kg/day) from gestational day 7 to 
21 • Control animals were fed with water. Synaptosomes from 6 brain pooled tissue homogenales run in duplicate using 9 concentrations of radioactive 
regions, namely the frontal cortex, striatum, hypothalamus, hippocampus, ligand. In a separate a �oup of animals Northern blot analysis were performed for 
cerebellum and brainstem were obtained from the offspring at 0, 1, 2, 3, 4 Individual subjects to deicrmine the D! and p2 rcccptor mRI；^ wna:ntrations. 
二 , 3 and 8 months postnatal for dopamine uptake binding assays. 陶 e 二 e 视 二 ！ 土 s 二 R ⑷ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ 
['Hlrnazindol. a dopamine uptake carrier, was used to measure the ^ i i±62 the NACC and CP, respectively). In addition the mRNA levels for the D2 
changes in uptake sites. Results showed that only the striatum showed an receptor were about 20% lower in the CP (p<0.06) and 40% lower in the NACC 
age-dependent increase in the no. of [^H]mazindol-labelled uptake sites (p< 0.005) in HR compared to LR. Moreover (here was an inverse correlation 
(0.05 - 1.91 pmol/mg protein) from 0 to 8 months. At 3 weeks postnatal, the (r = -0.45, p<0.05) between the amount of mRNA for the Dz rcccptor in the striatum of the cocaine-exposed group showed a maximun decrease of ？！八^C严cf 丨fjco«?iotor品o?? u> novej^ yf ere c^ Jjrcn污j^ y^ e^ f^ 
CO/ 4 二 。 。 , lao/ /Q Dz binding sites ui the MFC between HR (Bmax = 30:tl0) and LR (26±8) rals. HR 
43.5% in the no. of uptake sites and a 16% decrease in binding affinity ( B _ rats (Bmax = 780±27) showed a slightly (Scaler (p<0.05) number of Di binding 
» 1.44 pmol/mg protein, K^ - 16.53 nM for the control group and • sites in the NACC than LR rats (lmax = 660±26). No diffcrcnccs m number of 
0.813 pmol/mg protein, K^  = 13.91 nM for the cocaine-treated group). At 4 binding sites for Di receptors were observed between HR and LR rats in the CP 
weeks postnatal, only a 20.5% decrease in the no. of uptake sites was (8隨=1040±105 and 1120土98 respectively) or MFC (Bm«-5l.2±4 6 and 
detected in the cocaine-treated group. At 3 and 8 months postnataUhere is 
no significant difference in the no. of uptake sites and binding affinity for currently m progress to analyze the D2 rcccptor mRNA contcnl in the MFC and 
both the control and cocaine-treated group. The present data suggested the Di receptor mRNA content in all three redons. The results from the currcnt 
that the decrease in dopamine uptake binding in the cocaine-exposed studies further indicate that variation in the cfopamincrgic system contributes to 
offspring may result in the extracellular increase of dopamine content, thus individual differences. It also is the first demonstration that iherc^c post-synaptic 
rna^xWhe ^ f it^XtS^^^^ S ^ e ' ^ a 二 & 二 二 二 二 ^ 压 ^ 。 ^ ^ ; 
However, the lack of difference by 3 months may be reflective of a component of the dopaminergic system contributes to a greater extent to the 
compensatory mechanism indicative of a lack of permanent damage. differences between HR and LR than the Di system. 
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Short Communication 
Postnatal changes in [^H]mazindol-labelled dopamine uptake sites 
in the rat striatum following prenatal cocaine exposure 
Alfreda Stadlin a’*，Heung Ling Choi % David Tsang ^ 
�Department of Anatomy, Basic Medical Sciences Building：办 Department of Biochemistry, Chinese University of Hong Kong, Shatin, 
New Territories, Hong Kong 
(Accepted 23 November 1993) 
Abstract 
The present study showed that prenatal cocaine exposure (60 mg/kg/day) has a transient effect on the [^H]mazindol-labelled 
dopamine uptake sites in the striatum of the rat offspring examined from postnatal week 0-32. There is a 39% and 21% decrease 
in the number of binding sites in the cocaine-exposed group at postnatal weeks 3 and 4, respectively, with a recovery to 
near normal values by postnatal week 8. 
Key words: Cocaine; Prenatal; [^H]Mazindol; Dopamine uptake site; Striatum; Postnatal; Rat 
1. Introduction change in D A receptor binding and rate of DA turnover 
in the striatum [12]. The inconsistent results reported 
The mechanisms through which cocaine exerts its may be a reflection of the measurements taken at 
effects on the offspring from cocaine addicted mothers specific time points af ter prenatal cocaine exposure, 
are still largely unknown. Animal studies of prenatal thus it is unclear whether the results are reflective of 
cocaine exposure showed postnatal age-dependent be- the transient or long-term effects of prenatal cocaine 
havioral changes in locomotor activity [4,5,14,16,18,27, exposure. 
33,34], hyper-responsiveness to stress [2,19,23,33,35], It has been shown that in the adult, cocaine blocks 
delayed or accelerated acquisition of the righting reflex the reuptake of DA, norepinephrine (NE) and sero-
[14,34] and accelerated development in acoustic startle tonin [3] and the cocaine binding site on the DA 
response [7,34]. There are however, contrary reports to uptake sites has been implicated in the reinforcing and 
these animal studies revealing little or no behavioral addicting properties of cocaine [20,29]. It is therefore 
changes in the prenatally cocaine-exposed animals important to also evaluate the changes of the uptake 
[11,15,28,37]. sites in the offspring to further establish whether be-
A number of animal studies on prenatal cocaine havioral changes known to occur may be due to presy- — 
exposure also showed neurochemical changes such as naptic alterations in neurotransmitter function as well 
altered glucose metabolism and D^ dopamine (DA) as changes in the postsynaptic receptors. The present 
receptor binding in a number of dopaminergic brain study aims to investigate the changes in striatal uptake 
regions [8-10]. Changes in the dopaminergic system sites in the offspring exposed to cocaine prenatally at 
was also supported by studies showing a decrease in postnatal (PN) week 0，1，2，3，4，8，12, 32 in order to 
the number of electrophysiologically measured sponta- ascertain the short or long-term effects of cocaine, 
neously active DA cells [24]. Studies contrary to these, Seventy-seven female Sprague-Dawley rats (sup-
however, showed that there was either an increase in plied by the animal house of the Medical Faculty, 
D d a receptor binding in the striatum [32] or no Chinese University of Hong Kong) were used in this 
2 experiment. Animals were housed in stainless steel 
cages on a 12-h light/12-h dark cycle with free access 
to food and water. On gestational days 7-21, the 
* Corresponding author. Fax： (852) 6035031. pregnant rats were dosed orally once with 60 m g / k g / 
0006-8993/94 /$07.00 © 1994 Elsevier Science B.V. All rights reserved 
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day cocaine hydrochloride (Sigma Chemical, St. Louis, Table i 
N|IO). The control pregnant animals received an equiv- Effects of cocaine exposure on litter size, mean birth weight and 
alent vo lume of water. 60 m g / k g / d a y of cocaine was maternal weight gain during gestation day 7-21 (value 士 S.E.M.) 
chosen for this experiment because results f rom previ- ‘ Cocaine-
ous studies using cocaine doses ranging f rom 40-90 exposed 
m g / k g / d a y showed an increase in fetal anomalies if Litter size “ 12.9土2.8 i3.3±3.9 
the prenatal dose is greater than this d o s e [13] Mean maternal weight gain (g) 33 ±5.0 37 土 4.5 
Following delivery at PN d a y / w e e k 0，both dames Mean birth weight (g) 6.8±0.4 7.1 土0.5 
and pups were weighed, the mean maternal weight 
gain is measured as the difference in weight at gesta-
tioi|i day 7 and after delivery. Pups f rom each litter was filters were immersed into 3 ml scintillant and ex. 
c ime^ to 8 - 1 0 pups, keeping to a sex ratio as equal as tracted overnight; the radioactivity was quantitated in a 
p o s s ^ e . Pups from the cocaine group were not fos- Beckman LS1801 liquid scintillation counter at 48% 
tered to non-treated dams; their mothers did not re- efficiency. Aliquots of membrane preparations were 
f i v e any fur ther cocaine t rea tment af ter the day of used for the determination of protein content by the 
^e Cross-fostering was not used as the plasma method of Lowry [22] with bovine serum albumin as 
half-hfe of cocaine in the rat is in the range of 40-80 the standard. 
min [36], which would produce minimal residual effects Estimates of the equilibrium dissociation constant 
and thus would be expected to be rapidly cleared from (K^) and the number of binding sites (B ) were 
the mother 's body. Pups that were used for binding determined using the non-linear computer c u ^ e fitting 
assay studies beyond 28 days of age were weaned at PN program LIGAND [25]. Statistical differences were 
day 28 and housed in separate cages until the time tested at each specific age between the control and 
peri^od required for the studies. cocaine-exposed groups using an impaired Student's 
[H]maz indo l (23.5 C i / m m o l , Dupont-New Eng- t-test. Significance was assumed at the level of P < 0.05 
land Nuclear, Boston, MA) was used to determine the (*). Results are expressed as mean 土 S.E.M. 
n飞umber of uptake sites [17,29] in the striatum. Results from Table 1 showed that there was no 
[•^H]mazindol had been shown to bind with high affin- significant d i f ference be tween the control and 
ity to D A uptake sites in striatal membranes and to NE cocaine-exposed group in the mean litter size, the 
uptake sites in cerebral cortex and salivary glands [17]. mean maternal weight gain during gestational day 7 to 
On PN weeks 0，1’ 2，3, 4, 8，12，32，for each treatment 21 and the mean birth weight of the offspring. There 
group, 2 - 3 5 animals, depending on the quantity of was also no differences in the number of stillbirths and 
tissue needed for the binding assays, were selected at deformaties observed between the two groups (data 
random and sacrificed by decapitation. A total of 477 not shown). 
pups each for the two treatment groups were used for The specific binding of pH]mazindol in the striatum 
the binding studies. The binding assay for each time was 87%. Since the striatum contains mainly dopamin-
course and each treatment group was repeated three ergic terminals, it is therefore assumed that the high 
times, the offspring of each repeated assay were from specific binding value measured is due to the binding 
different pregnant dams. to the D A uptake sites. Table 2 showed the Scatchard 
The striatum studied were homogenized with 40 analysis of [^H]mazindol-Iabelled D A uptake sites in 
vols, of ice-cold 50 mM Tris-HCl buffer with 120 mM the striatum from PN weeks 0-32 . In the control 
NaCl and 5 mM KCl (pH 7.4) and centrifuged at group, there was an eightfold increase in the number 
50,000 g for 10 min and the resulting pellets washed of [^H]mazindol-labelled D A uptake sites (B^^) from 
twice. The final pellets were rapidly f rozen on dry ice- - PN weeks- 0 - 4 (0:21 土 0.22 to 1.71 土 0.04 p m o l / m g 
and stored at - 70°C until assayed, usually within 2 protein) with minimal change in number thereafter. In 
weeks of initial homogenization. On the day of binding the cocaine-exposed group, at PN week 3，there was a 
assay, samples were thawed at 4 � C and resuspened in decrease of 39% (P < 0.05) in the number of D A 
10 vols, of 50 mM Tris-HCl buffer (as above). 50 jxl uptake sites as compared to the control group. At PN 
aliquots of tissue sample (protein concentrat ion of 1.0 week 4，there is a 21% (P < 0.05) decrease in B^^ in 
m g / m l ) were incubated in triplicate in a total vols, of the cocaine-exposed group when compared to that of 
500 /xl. After 30 min incubation at 4 � C with the control. By PN week 8，there was only a 10% 
[•^H]mazindoI (1.56-33 nM was used for the Scatchard decrease (not statistically significant) in the number of 
analysis), the samples were filtered rapidly through DA uptake sites between the control and cocaine-ex-
Whatman G F / B filters with a Brandel Cell Harvester posed groups. At PN week 32, there appeared to be a 
followed by washing of the filters ( 3 x 5 ml Tris-HCl reversal of trend (although not significant) with the 
buffer at 4�C). 15 ^tM nomifensine (Research Biochem- cocaine-exposed group having a 12% higher number of 
icals, MA) was used to define specific binding. The binding sites as compared to that of the control. 
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Table 2 
P ? m a z i n d o l binding and � t o striatal membrane in control . . ^ T T ^ T " " T f T l 二 d e j e c t e d o n g e s t a t i o n 
and cocaine-exposed rat offspring day lZ-14 in the rat [21,26,31] and were also shown to 
Weeks fl随(pmol/mg p r o t e i n ) ~ ^ J i m unde rgo r a p i d d i f f e r e n t i a t i o n d u r i n g the last 8 days o f 
^ ^ C o c a i n e - ~ ~ ^ ― T " 『 S t a t i o n [，w i t h subsequent increases in D A levels 
exposed from gestation day 17，reaching adult levels at PN 60 
" 5 0 . 2 1 士0.22 0 . 1 4土0 . 0 6 1 6 . 8 4土6 10 11 80 + 446 f ' ^ V " [31】.Most of the D , recep-
1 0.51 土0.15 0.51 ±0.07 19 6115 15 1967；204 formation of rat dopaminergic neurons occured 
2 1.15土0.08 1,13±0.15 17.92±3.40 19 postnatally and reached an end at PN week 4 [21]. The 
3 1.53士0.12 0.93士0.16 * 14.99±1.53 14.73±L17 present results show that D A uptake sites also reached 
J 1.71 土0.04 1.35土0.08 * 13.78土0.14 12.04±0.50 adul t levels by P N w e e k 4. T h e changes in [^Hjmazin-
12 170^028 16.31 ±0.84 dol-labelled D A uptake sites at PN weeks 3 and 4 
32 u l t o l s 1：98±0：26 ；973±49； development associated with prenatal cocaine exposure 
A H — T 7 — ^ — — m this Study suggested that the prenatal insult of fpr r 二 “ was found in cocaine-treated off- dopaminergic neurons during development may result s严ing at riN weeks 3 and 4. Membranes were incubated with o r v ^ r i � H � f j r ‘. , . ‘ l^H]mazindol (1.56-33 nM) with or without 15 /JM of nomifensine. ^ & P e n o d of postnatal dysfunctional maturation Of 
A^  = 9，at each time point, measurement was in triplicate with each d o p a m i n e u p t a k e sites. R e s u l t s f r o m the presen t Study 
experiment repeated three times independently. * p<0.05 signifi- are also in agreement with Other prenatal cocaine 
cant difference from the water control. exposure studies showing morphological, physiological 
and biochemical changes in dopaminergic neurons at 
PN week 3 and 4 [1,30,32] suggesting that this may be a 
, . critical period during which prenatal cocaine exposure 
The binding affinity ranged f rom K^ = 13.78 士 0.14 may have an important effect. 
to 19.73 士 4.97 nM for the control and 11.80 土 4.46 to It had been shown that dopaminergic cells demon-
19.62 士 2.04 nM for the cocaine-exposed group from strate enormous plasticity after dopaminergic lesion; 
PN weeks 0-32 . There was no significant difference normal dopaminergic function can still exist with only a 
observed in the binding affinity between the two groups < 10% dopaminergic transmission capacity remaining 
at all the ages studied (Table 2). [21]. The authors suggested that some operative com-
In this study, it is reported for the first time that pensatory mechanism may exist to enable the normal 
prenatal cocaine exposure from gestational day 7 -21 function of the dopaminergic cells when the cells are 
exerts an effect on [^H]mazindol-labelled D A uptake subjected to insults. Although it is difficult to predict 
sites in the rat striatum of the offspring. Since there whether the decreased in the number of [^Hjmazindol-
are no significant changes in litter size, offspring birth labelled D A uptake sites due to prenatal cocaine expo-
weight and maternal weight gain during gestation days sure in the present study may result in an overall 
7-21，the consequences of exposure to 60 m g / k g dose change in behavior, it is however clear that the effects 
of cocaine during gestation may not be related to the are transient. Therefore it is not unreasonable to as-
potential nutritional alterations during fetal develop- sume that a compensatory mechanism may exist after 
ment. prenatal cocaine insult which enables the recovery of 
Scatchard analysis of striatal tissue indicated that the number of DA uptake sites to near normal levels, 
there was a significant decrease in with no signifi-
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